type	accession	study_title	bioproject_accession	registration_date	project.project_id	publication.publication_id
sra	SRP097738	esBAF chromatin remodeling complexes promote spacing of nucleosomes flanking pluripotency factor binding sites	PRJNA368640	25-Jan-2017	R01CA163915	28250416
sra	SRP097738	esBAF chromatin remodeling complexes promote spacing of nucleosomes flanking pluripotency factor binding sites	PRJNA368640	25-Jan-2017	R01CA163915
sra	SRP097737	TOP2 synergizes with BAF chromatin remodeling for resolution of facultative heterochromatin	PRJNA368641	25-Jan-2017	R01CA163915	28250416
sra	SRP097737	TOP2 synergizes with BAF chromatin remodeling for resolution of facultative heterochromatin	PRJNA368641	25-Jan-2017	R01CA163915
sra	SRP091873	Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells	PRJNA349475	20-Oct-2016	R01CA211927	28272465
sra	SRP091873	Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells	PRJNA349475	20-Oct-2016	R01CA211927
sra	SRP102091	Chromatin-associated protein interactions drive megadomain formation in NUT midline carcinoma	PRJNA379616	17-Mar-2017	R01CA124633	28484033
sra	SRP102091	Chromatin-associated protein interactions drive megadomain formation in NUT midline carcinoma	PRJNA379616	17-Mar-2017	R01CA124633
sra	SRP096375	Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B	PRJNA360859	10-Jan-2017	P01CA155258	28487543
sra	SRP096375	Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B	PRJNA360859	10-Jan-2017	P01CA155258
sra	SRP106708	Analysis of gene expression in p53-null cell types following deletion of Mdm2	PRJNA385963	9-May-2017	R01CA181204	28576884
sra	SRP106708	Analysis of gene expression in p53-null cell types following deletion of Mdm2	PRJNA385963	9-May-2017	R01CA181204
sra	SRP108222	AR-independent prostate cancer is sustained through FGF signaling	PRJNA388341	29-May-2017	U54CA224079	29017058
sra	SRP108222	AR-independent prostate cancer is sustained through FGF signaling	PRJNA388341	29-May-2017	U54CA224079
sra	SRP094781	Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy	PRJNA356761	8-Dec-2016	R01CA205426	29033130
sra	SRP094781	Molecular portraits of tumor mutational and micro-environmental sculpting by immune checkpoint blockade therapy	PRJNA356761	8-Dec-2016	R01CA205426
sra	SRP092083	Suppression of adaptive responses to targeted cancer therapy by transcriptional repression [ChIP-seq]	PRJNA350359	24-Oct-2016	P01CA154303	29054992
sra	SRP092083	Suppression of adaptive responses to targeted cancer therapy by transcriptional repression [ChIP-seq]	PRJNA350359	24-Oct-2016	P01CA154303
sra	SRP064353	RNA-Seq data for AKT, BAD, ERBB2, IGF1R, RAF1 and ERK1 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells	PRJNA297451	30-Sep-2015	U54CA209978	29093439
sra	SRP064353	RNA-Seq data for AKT, BAD, ERBB2, IGF1R, RAF1 and ERK1 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells	PRJNA297451	30-Sep-2015	U54CA209978
sra	SRP092523	Single-cell profiling of tumor infiltrating T cells	PRJNA352336	3-Nov-2016	P01CA154303	29101163
sra	SRP092523	Single-cell profiling of tumor infiltrating T cells	PRJNA352336	3-Nov-2016	P01CA154303
sra	SRP081517	Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively	PRJNA338785	12-Aug-2016	U54CA224079	29153843
sra	SRP081517	Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively	PRJNA338785	12-Aug-2016	U54CA224079
sra	SRP081515	Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media	PRJNA338786	12-Aug-2016	U54CA224079	29153843
sra	SRP081515	Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media	PRJNA338786	12-Aug-2016	U54CA224079
sra	SRP081514	HNF4G, AR, FOXA1, H3K4me1, H3K27acetyl binding sites upon knockdown and overexpression of HNF4G in 22Rv1 and LNCaP prostate cancer cells respectively	PRJNA338787	12-Aug-2016	U54CA224079	29153843
sra	SRP081514	HNF4G, AR, FOXA1, H3K4me1, H3K27acetyl binding sites upon knockdown and overexpression of HNF4G in 22Rv1 and LNCaP prostate cancer cells respectively	PRJNA338787	12-Aug-2016	U54CA224079
sra	SRP118933	Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils	PRJNA412257	26-Sep-2017	R01AI084880	29191879
sra	SRP118933	Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils	PRJNA412257	26-Sep-2017	R01AI084880
sra	SRP125486	How HLA influences response to immunotherapy (Part 3)	PRJNA419530	22-Nov-2017	R01CA205426	29217585
sra	SRP125486	How HLA influences response to immunotherapy (Part 3)	PRJNA419530	22-Nov-2017	R01CA205426
sra	SRP199253	A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing	PRJNA544340	22-May-2019	U24CA224316	29301958
sra	SRP199253	A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing	PRJNA544340	22-May-2019	U24CA224316
sra	SRP126091	A Major Chromatin Regulator Determines Resistance of Tumor Cells to T cell Mediated Killing	PRJNA420997	4-Dec-2017	U24CA224316	29301958
sra	SRP126091	A Major Chromatin Regulator Determines Resistance of Tumor Cells to T cell Mediated Killing	PRJNA420997	4-Dec-2017	U24CA224316
sra	SRP125218	Peptidomimetic blockade of MYB in acute myeloid leukemia [H3K27ac ChIP-seq]	PRJNA418963	17-Nov-2017	R01CA204396	29317678
sra	SRP125218	Peptidomimetic blockade of MYB in acute myeloid leukemia [H3K27ac ChIP-seq]	PRJNA418963	17-Nov-2017	R01CA204396
sra	SRP098166	Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq]	PRJNA369119	27-Jan-2017	R01CA204396	29317678
sra	SRP098166	Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq]	PRJNA369119	27-Jan-2017	R01CA204396
sra	SRP098163	Peptidomimetic blockade of MYB in acute myeloid leukemia [MYB ChIP-seq]	PRJNA369116	27-Jan-2017	R01CA204396	29317678
sra	SRP098163	Peptidomimetic blockade of MYB in acute myeloid leukemia [MYB ChIP-seq]	PRJNA369116	27-Jan-2017	R01CA204396
sra	SRP120988	Analysis of genome-wide accessibility following acute deletion of Ring1b in mouse embryonic stem cells [ATAC-seq]	PRJNA415436	23-Oct-2017	R01CA163915	29323272
sra	SRP120988	Analysis of genome-wide accessibility following acute deletion of Ring1b in mouse embryonic stem cells [ATAC-seq]	PRJNA415436	23-Oct-2017	R01CA163915
sra	SRP106553	Effects of dominant-negative G784E Smarca4 mutation on enhancer marks and factors in mouse embryonic stem cells [ChIP-seq]	PRJNA385663	5-May-2017	R01CA163915	29323272
sra	SRP106553	Effects of dominant-negative G784E Smarca4 mutation on enhancer marks and factors in mouse embryonic stem cells [ChIP-seq]	PRJNA385663	5-May-2017	R01CA163915
sra	SRP106196	Effects of dominant-negative Smarca4 mutations on the DNA accessibility landscape [ATAC-seq]	PRJNA385199	2-May-2017	R01CA163915	29323272
sra	SRP106196	Effects of dominant-negative Smarca4 mutations on the DNA accessibility landscape [ATAC-seq]	PRJNA385199	2-May-2017	R01CA163915
sra	SRP106076	Transcriptional effects of dominant-negative G784E Smarca4 mutation in mouse embryonic stem cells [RNA-seq]	PRJNA385176	2-May-2017	R01CA163915	29323272
sra	SRP106076	Transcriptional effects of dominant-negative G784E Smarca4 mutation in mouse embryonic stem cells [RNA-seq]	PRJNA385176	2-May-2017	R01CA163915
sra	SRP115262	Rheostatic Chromatin Control of Promiscuous Transcription by Aire and Brg1 [ATAC-Seq]	PRJNA397970	11-Aug-2017	R01CA163915	29335648
sra	SRP115262	Rheostatic Chromatin Control of Promiscuous Transcription by Aire and Brg1 [ATAC-Seq]	PRJNA397970	11-Aug-2017	R01CA163915
sra	SRP073740	Transcriptional effect of ETV1 knockdown in melanoma cells	PRJNA319396	15-Apr-2016	U54CA224079	29360641
sra	SRP073740	Transcriptional effect of ETV1 knockdown in melanoma cells	PRJNA319396	15-Apr-2016	U54CA224079
sra	SRP073739	ETV1 binding sites in GIST and Melanoma cells	PRJNA319395	19-Apr-2016	U54CA224079	29360641
sra	SRP073739	ETV1 binding sites in GIST and Melanoma cells	PRJNA319395	19-Apr-2016	U54CA224079
sra	SRP073337	Role of COP1 on MAP kinase transcriptional output in melanoma	PRJNA318531	14-Apr-2016	U54CA224079	29360641
sra	SRP073337	Role of COP1 on MAP kinase transcriptional output in melanoma	PRJNA318531	14-Apr-2016	U54CA224079
sra	SRP073110	Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [ChIP-seq]	PRJNA318044	11-Apr-2016	P01CA155258	29379199
sra	SRP073110	Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [ChIP-seq]	PRJNA318044	11-Apr-2016	P01CA155258
sra	SRP110588	Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [ChIP-seq Th-MYCN]	PRJNA392062	27-Jun-2017	P01CA155258	29379199
sra	SRP110588	Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [ChIP-seq Th-MYCN]	PRJNA392062	27-Jun-2017	P01CA155258
sra	SRP073112	Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [RNA-seq]	PRJNA318042	11-Apr-2016	P01CA155258	29379199
sra	SRP073112	Enhancer invasion shapes MYCN dependent transcriptional amplification in neuroblastoma [RNA-seq]	PRJNA318042	11-Apr-2016	P01CA155258
sra	SRP125209	MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [ATAC-seq]	PRJNA418959	17-Nov-2017	R01CA204396	29431698
sra	SRP125209	MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [ATAC-seq]	PRJNA418959	17-Nov-2017	R01CA204396
sra	SRP125208	MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665]	PRJNA418960	17-Nov-2017	R01CA204396	29431698
sra	SRP125208	MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665]	PRJNA418960	17-Nov-2017	R01CA204396
sra	SRP098784	MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C]	PRJNA369743	3-Feb-2017	R01CA204396	29431698
sra	SRP098784	MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C]	PRJNA369743	3-Feb-2017	R01CA204396
sra	SRP102810	High-efficiency RNA-based reprogramming of human primary fibroblasts	PRJNA381150	31-Mar-2017	R01AI124487	29467427
sra	SRP102810	High-efficiency RNA-based reprogramming of human primary fibroblasts	PRJNA381150	31-Mar-2017	R01AI124487
sra	SRP090392	BRCA1/RNApII regulation in Ewing''s sarcoma (ChIP-seq)	PRJNA344334	23-Sep-2016	R01CA204915	29513652
sra	SRP090392	BRCA1/RNApII regulation in Ewing''s sarcoma (ChIP-seq)	PRJNA344334	23-Sep-2016	R01CA204915
sra	SRP130991	mRNA profiles in PAF KO intestinal adenoma	PRJNA430110	15-Jan-2018	P50CA098258	29533773
sra	SRP130991	mRNA profiles in PAF KO intestinal adenoma	PRJNA430110	15-Jan-2018	P50CA098258
sra	SRP110503	Epigenomic analysis of Atrx deficiency in murine glioma cells of orgin [ATAC-seq]	PRJNA391904	26-Jun-2017	R01CA204136	29535300
sra	SRP110503	Epigenomic analysis of Atrx deficiency in murine glioma cells of orgin [ATAC-seq]	PRJNA391904	26-Jun-2017	R01CA204136
sra	SRP110502	Epigenomic analysis of Atrx deficiency in murine glioma cells of orgin [Atrx ChIP]	PRJNA391902	26-Jun-2017	R01CA204136	29535300
sra	SRP110502	Epigenomic analysis of Atrx deficiency in murine glioma cells of orgin [Atrx ChIP]	PRJNA391902	26-Jun-2017	R01CA204136
sra	SRP133767	Widespread intronic polyadenylation diversifies immune cell transcriptomes	PRJNA436569	1-Mar-2018	P01CA155258	29712909
sra	SRP133767	Widespread intronic polyadenylation diversifies immune cell transcriptomes	PRJNA436569	1-Mar-2018	P01CA155258
sra	SRP092637	Genome-wide gene-expression profile of mouse intestinal stem cells	PRJNA352598	5-Nov-2016	U54CA224068	29727683
sra	SRP092637	Genome-wide gene-expression profile of mouse intestinal stem cells	PRJNA352598	5-Nov-2016	U54CA224068
sra	SRP133187	RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells	PRJNA434757	20-Feb-2018	P50CA186786	29808028
sra	SRP133187	RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells	PRJNA434757	20-Feb-2018	P50CA186786
sra	SRP117692	TMPRSS2-ERG suppresses PTEN/TP53 alteration-induced cancer lineage plasticity	PRJNA407356	14-Sep-2017	U54CA224079	29844131
sra	SRP117692	TMPRSS2-ERG suppresses PTEN/TP53 alteration-induced cancer lineage plasticity	PRJNA407356	14-Sep-2017	U54CA224079
sra	SRP136348	Disruption of TET-2 promotes the therapeutic efficacy of CD19-targeted T-cells	PRJNA445447	23-Mar-2018	P01CA214278	29849141
sra	SRP136348	Disruption of TET-2 promotes the therapeutic efficacy of CD19-targeted T-cells	PRJNA445447	23-Mar-2018	P01CA214278
sra	SRP136706	Genome-wide chromatin accessibility profiles of TET2-disrupted T cells from a chronic lymphocytic leukemia (CLL) patient.	PRJNA447963	29-Mar-2018	P01CA214278	29849141
sra	SRP136706	Genome-wide chromatin accessibility profiles of TET2-disrupted T cells from a chronic lymphocytic leukemia (CLL) patient.	PRJNA447963	29-Mar-2018	P01CA214278
sra	SRP142614	RNA-seq of CD33 KO and control HSPCs	PRJNA453558	25-Apr-2018	P01CA214278	29856956
sra	SRP142614	RNA-seq of CD33 KO and control HSPCs	PRJNA453558	25-Apr-2018	P01CA214278
sra	SRP137894	Methylation profile of neuroendocrine prostate cancer models	PRJNA449098	6-Apr-2018	U54CA224079	29921838
sra	SRP137894	Methylation profile of neuroendocrine prostate cancer models	PRJNA449098	6-Apr-2018	U54CA224079
sra	SRP137893	Molecular characterization of neuroendocrine prostate cancer organoids and PDOX by RNA-seq	PRJNA449096	5-Apr-2018	U54CA224079	29921838
sra	SRP137893	Molecular characterization of neuroendocrine prostate cancer organoids and PDOX by RNA-seq	PRJNA449096	5-Apr-2018	U54CA224079
sra	SRP139944	Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments	PRJNA450084	13-Apr-2018	R01CA197363	29942093
sra	SRP139944	Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments	PRJNA450084	13-Apr-2018	R01CA197363
sra	SRP139554	Metabolic signaling directs the reciprocal lineage decisions of aß and ?d T cells	PRJNA449676	11-Apr-2018	R01CA221290	29980617
sra	SRP139554	Metabolic signaling directs the reciprocal lineage decisions of aß and ?d T cells	PRJNA449676	11-Apr-2018	R01CA221290
sra	SRP098949	Systematic assessment of next-generation sequencing for quantitative small RNA profiling: synthetic ratiometric pools	PRJNA371517	6-Feb-2017	P50CA186786	30010675
sra	SRP098949	Systematic assessment of next-generation sequencing for quantitative small RNA profiling: synthetic ratiometric pools	PRJNA371517	6-Feb-2017	P50CA186786
sra	SRP098948	Systematic assessment of next-generation sequencing for quantitative small RNA profiling: synthetic equimolar pool	PRJNA371514	6-Feb-2017	P50CA186786	30010675
sra	SRP098948	Systematic assessment of next-generation sequencing for quantitative small RNA profiling: synthetic equimolar pool	PRJNA371514	6-Feb-2017	P50CA186786
sra	SRP098943	Systematic assessment of next-generation sequencing for quantitative small RNA profiling: human plasma pool	PRJNA371503	6-Feb-2017	P50CA186786	30010675
sra	SRP098943	Systematic assessment of next-generation sequencing for quantitative small RNA profiling: human plasma pool	PRJNA371503	6-Feb-2017	P50CA186786
sra	SRP148788	Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides	PRJNA472771	23-May-2018	P01AI118688	30022165
sra	SRP148788	Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides	PRJNA472771	23-May-2018	P01AI118688
sra	SRP148866	Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses (ATAC-seq)	PRJNA472897	24-May-2018	U01CA217885	30038220
sra	SRP148866	Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses (ATAC-seq)	PRJNA472897	24-May-2018	U01CA217885
sra	SRP148173	Therapeutic efficacy of BET bromodomain protein inhhibitor and PD-1 blockade in genetically engineered mouse model of non-small cell lung cancer	PRJNA471887	17-May-2018	P01CA154303	30087114
sra	SRP148173	Therapeutic efficacy of BET bromodomain protein inhhibitor and PD-1 blockade in genetically engineered mouse model of non-small cell lung cancer	PRJNA471887	17-May-2018	P01CA154303
sra	SRP150548	Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma	PRJNA476140	14-Jun-2018	R33CA225291	30127394
sra	SRP150548	Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma	PRJNA476140	14-Jun-2018	U54CA224070	30127394
sra	SRP150548	Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma	PRJNA476140	14-Jun-2018	R33CA225291
sra	SRP150548	Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma	PRJNA476140	14-Jun-2018	U54CA224070
sra	SRP153810	Discovery of a Pro-Tumoral Clonogenic Unipotent Neutrophil Progenitor in Mouse and Human Bone Marrow	PRJNA481252	16-Jul-2018	U01CA224766	30157427
sra	SRP153810	Discovery of a Pro-Tumoral Clonogenic Unipotent Neutrophil Progenitor in Mouse and Human Bone Marrow	PRJNA481252	16-Jul-2018	U01CA224766
sra	SRP153808	Identification of an Early Unipotent Neutrophil Progenitor with Pro-Tumoral Activity in Mouse and Human Bone Marrow	PRJNA481247	16-Jul-2018	U01CA224766	30157427
sra	SRP153808	Identification of an Early Unipotent Neutrophil Progenitor with Pro-Tumoral Activity in Mouse and Human Bone Marrow	PRJNA481247	16-Jul-2018	U01CA224766
sra	SRP144074	Transcriptional effects of small molecule targeting of ARID1A	PRJNA454308	30-Apr-2018	R01CA163915	30197195
sra	SRP144074	Transcriptional effects of small molecule targeting of ARID1A	PRJNA454308	30-Apr-2018	R01CA163915
sra	SRP102097	Genome-wide maps of histone H3K27 acetylation in A549 and MSR-A549 cells.	PRJNA379622	17-Mar-2017	P01CA154303	30205046
sra	SRP102097	Genome-wide maps of histone H3K27 acetylation in A549 and MSR-A549 cells.	PRJNA379622	17-Mar-2017	U01CA217885	30205046
sra	SRP102097	Genome-wide maps of histone H3K27 acetylation in A549 and MSR-A549 cells.	PRJNA379622	17-Mar-2017	P01CA154303
sra	SRP102097	Genome-wide maps of histone H3K27 acetylation in A549 and MSR-A549 cells.	PRJNA379622	17-Mar-2017	U01CA217885
sra	SRP102140	mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment	PRJNA379664	17-Mar-2017	P01CA154303	30205046
sra	SRP102140	mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment	PRJNA379664	17-Mar-2017	U01CA217885	30205046
sra	SRP102140	mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment	PRJNA379664	17-Mar-2017	P01CA154303
sra	SRP102140	mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment	PRJNA379664	17-Mar-2017	U01CA217885
sra	SRP092620	Inhibition of MEK and ATR induces synergistic killing of a Mll-Af4 B-ALL model harboring activated Ras mutation	PRJNA352549	4-Nov-2016	R01CA176745	30266823
sra	SRP092620	Inhibition of MEK and ATR induces synergistic killing of a Mll-Af4 B-ALL model harboring activated Ras mutation	PRJNA352549	4-Nov-2016	R01CA176745
sra	SRP123227	Transcript analysis of CD45+Ter119+CD71+ erythroid-like progenitor cells from tumor-bearing mice	PRJNA416659	31-Oct-2017	R33CA225328	30297899
sra	SRP123227	Transcript analysis of CD45+Ter119+CD71+ erythroid-like progenitor cells from tumor-bearing mice	PRJNA416659	31-Oct-2017	R33CA225328
sra	SRP154583	Differences in microRNA expression in breast cancer between women of African and European ancestry	PRJNA482141	20-Jul-2018	U24CA232979	30321299
sra	SRP154583	Differences in microRNA expression in breast cancer between women of African and European ancestry	PRJNA482141	20-Jul-2018	U24CA232979
sra	SRP155033	Colonic adenoma and adjacent normal single-cell RNA-seq	PRJNA482649	24-Jul-2018	U2CCA233291	30346945
sra	SRP155033	Colonic adenoma and adjacent normal single-cell RNA-seq	PRJNA482649	24-Jul-2018	U2CCA233291
sra	SRP144614	Colonic single-cell RNA-seq experiment	PRJNA461797	4-May-2018	U2CCA233291	30346945
sra	SRP144614	Colonic single-cell RNA-seq experiment	PRJNA461797	4-May-2018	U2CCA233291
sra	SRP132307	Differential Gene expression in the mouse mammary tumors of  PyMT-Malat1 wild-type (WT), PyMT-Malat1 knockout (KO) and PyMT-Malat1 knockout with Malat1 transgene expression (TG)	PRJNA433234	6-Feb-2018	U24CA209851	30349115
sra	SRP132307	Differential Gene expression in the mouse mammary tumors of  PyMT-Malat1 wild-type (WT), PyMT-Malat1 knockout (KO) and PyMT-Malat1 knockout with Malat1 transgene expression (TG)	PRJNA433234	6-Feb-2018	U24CA209851
sra	SRP150315	Bone marrow derived human B cells [normal proB]	PRJNA475684	12-Jun-2018	U01CA232563	30357359
sra	SRP150315	Bone marrow derived human B cells [normal proB]	PRJNA475684	12-Jun-2018	U01CA232563
sra	SRP150314	Aberrant splicing in B-cell acute lymphoblastic leukemia [cell line]	PRJNA475682	12-Jun-2018	U01CA232563	30357359
sra	SRP150314	Aberrant splicing in B-cell acute lymphoblastic leukemia [cell line]	PRJNA475682	12-Jun-2018	U01CA232563
sra	SRP123595	T helper cells modulate intestinal stem cell renewal and differentiation	PRJNA417070	3-Nov-2017	U54CA224068	30392957
sra	SRP123595	T helper cells modulate intestinal stem cell renewal and differentiation	PRJNA417070	3-Nov-2017	U54CA224068
sra	SRP140441	Elucidating the role of glycogen debranching enzyme AGL in bladder carcinogenesis by generation and characterization of knockout mice	PRJNA450320	16-Apr-2018	R01CA143971	30403777
sra	SRP140441	Elucidating the role of glycogen debranching enzyme AGL in bladder carcinogenesis by generation and characterization of knockout mice	PRJNA450320	16-Apr-2018	R01CA143971
sra	SRP162041	Targeting the CALR Interactome in Myeloproliferative Neoplasms	PRJNA491714	18-Sep-2018	R01CA204396	30429377
sra	SRP162041	Targeting the CALR Interactome in Myeloproliferative Neoplasms	PRJNA491714	18-Sep-2018	R01CA204396
sra	SRP140587	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [ChIP-seq]	PRJNA450476	16-Apr-2018	R01CA176745	30431433
sra	SRP140587	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [ChIP-seq]	PRJNA450476	16-Apr-2018	R01CA204915	30431433
sra	SRP140587	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [ChIP-seq]	PRJNA450476	16-Apr-2018	R01CA176745
sra	SRP140587	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [ChIP-seq]	PRJNA450476	16-Apr-2018	R01CA204915
sra	SRP140586	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq]	PRJNA450466	16-Apr-2018	R01CA176745	30431433
sra	SRP140586	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq]	PRJNA450466	16-Apr-2018	R01CA204915	30431433
sra	SRP140586	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq]	PRJNA450466	16-Apr-2018	R01CA176745
sra	SRP140586	Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq]	PRJNA450466	16-Apr-2018	R01CA204915
sra	SRP149518	Evaluating pre-clinical models for studying NASH driven HCC.	PRJNA474086	1-Jun-2018	U01AA027681	30449681
sra	SRP149518	Evaluating pre-clinical models for studying NASH driven HCC.	PRJNA474086	1-Jun-2018	U01AA027681
sra	SRP161930	Lung adenocarcinoma UNC0638 gene expression	PRJNA491480	17-Sep-2018	P01CA154303	30455465
sra	SRP161930	Lung adenocarcinoma UNC0638 gene expression	PRJNA491480	17-Sep-2018	P01CA154303
sra	SRP141216	H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression (experiment 2)	PRJNA451026	19-Apr-2018	P01CA154303	30455465
sra	SRP141216	H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression (experiment 2)	PRJNA451026	19-Apr-2018	P01CA154303
sra	SRP162854	IKZF2 is required for myeloid leukemic stem cells by driving self-renewal and inhibiting the myeloid differentiation program II	PRJNA493794	28-Sep-2018	R01CA176745	30472158
sra	SRP162854	IKZF2 is required for myeloid leukemic stem cells by driving self-renewal and inhibiting the myeloid differentiation program II	PRJNA493794	28-Sep-2018	R01CA176745
sra	SRP127266	IKZF2 is required for myeloid leukemic stem cells by driving self-renewal and inhibiting the myeloid differentiation program I	PRJNA423273	20-Dec-2017	R01CA176745	30472158
sra	SRP127266	IKZF2 is required for myeloid leukemic stem cells by driving self-renewal and inhibiting the myeloid differentiation program I	PRJNA423273	20-Dec-2017	R01CA176745
sra	SRP133326	Single cell RNA-seq of IL-10-producing CD4 T cells during chronic LCMV infection	PRJNA435611	22-Feb-2018	R01CA203923	30487586
sra	SRP133326	Single cell RNA-seq of IL-10-producing CD4 T cells during chronic LCMV infection	PRJNA435611	22-Feb-2018	R01CA203923
sra	SRP133325	RNA-seq of Tfh IL21+ single producers and Tfh IL21+ IL10+ double producers	PRJNA435612	22-Feb-2018	R01CA203923	30487586
sra	SRP133325	RNA-seq of Tfh IL21+ single producers and Tfh IL21+ IL10+ double producers	PRJNA435612	22-Feb-2018	R01CA203923
sra	SRP133828	Organoid modeling of the tumor immune microenvironment	PRJNA436710	2-Mar-2018	U54CA224081	30550791
sra	SRP133828	Organoid modeling of the tumor immune microenvironment	PRJNA436710	2-Mar-2018	U54CA224081
sra	SRP139591	Transcript analysis of multi-locus sampled tumor tissue in patients with non-small cell lung cancer	PRJNA449697	11-Apr-2018	R33CA225328	30560866
sra	SRP139591	Transcript analysis of multi-locus sampled tumor tissue in patients with non-small cell lung cancer	PRJNA449697	11-Apr-2018	R33CA225328
sra	SRP166318	Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity [scRNA-seq]	PRJNA497860	22-Oct-2018	R01CA221290	30568299
sra	SRP166318	Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity [scRNA-seq]	PRJNA497860	22-Oct-2018	R01CA221290
sra	SRP166317	Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity [ATAC-seq]	PRJNA497861	22-Oct-2018	R01CA221290	30568299
sra	SRP166317	Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity [ATAC-seq]	PRJNA497861	22-Oct-2018	R01CA221290
sra	SRP167870	Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells	PRJNA503859	5-Nov-2018	P01CA154303	30575730
sra	SRP167870	Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells	PRJNA503859	5-Nov-2018	P01CA154303
sra	SRP073902	Non-overlapping control of transcriptome by Promoter and Super-Enhancer-Associated Dependencies	PRJNA319620	26-Apr-2016	P01CA155258	30590042
sra	SRP073902	Non-overlapping control of transcriptome by Promoter and Super-Enhancer-Associated Dependencies	PRJNA319620	26-Apr-2016	P01CA155258
sra	SRP151196	Homolog-selective degradation as a strategy to probe the function of CDK6 in AML	PRJNA477657	23-Jun-2018	P01CA154303	30595531
sra	SRP151196	Homolog-selective degradation as a strategy to probe the function of CDK6 in AML	PRJNA477657	23-Jun-2018	P01CA154303
sra	SRP165173	SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors	PRJNA495756	11-Oct-2018	R01CA204314	30605687
sra	SRP165173	SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors	PRJNA495756	11-Oct-2018	R01CA204314
sra	SRP158590	Molecular Signatures of Multiple Myeloma Progression through Single Cell RNA-Seq	PRJNA487220	22-Aug-2018	U54CA224018	30607001
sra	SRP158590	Molecular Signatures of Multiple Myeloma Progression through Single Cell RNA-Seq	PRJNA487220	22-Aug-2018	U54CA224018
sra	SRP139047	Arg1 expression defines immunosuppressive subsets of immune infiltrating cells in cancer	PRJNA449347	9-Apr-2018	R01AI084880	30613266
sra	SRP139047	Arg1 expression defines immunosuppressive subsets of immune infiltrating cells in cancer	PRJNA449347	9-Apr-2018	R01AI084880
sra	SRP140568	Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq]	PRJNA450436	16-Apr-2018	R01CA176745	30630822
sra	SRP140568	Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq]	PRJNA450436	16-Apr-2018	R01CA176745
sra	SRP140559	Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [ChIP-seq]	PRJNA450432	16-Apr-2018	R01CA176745	30630822
sra	SRP140559	Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [ChIP-seq]	PRJNA450432	16-Apr-2018	R01CA176745
sra	SRP101890	Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq]	PRJNA379175	14-Mar-2017	U24CA180996	30643296
sra	SRP101890	Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq]	PRJNA379175	14-Mar-2017	U24CA180996
sra	SRP163059	GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance	PRJNA494242	1-Oct-2018	U54CA224079	30644358
sra	SRP163059	GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance	PRJNA494242	1-Oct-2018	U54CA224079
sra	SRP163001	GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance	PRJNA494088	1-Oct-2018	U54CA224079	30644358
sra	SRP163001	GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance	PRJNA494088	1-Oct-2018	U54CA224079
sra	SRP159024	Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy	PRJNA488272	28-Aug-2018	U54CA224079	30664790
sra	SRP159024	Targeting the perivascular niche sensitizes disseminated tumour cells to chemotherapy	PRJNA488272	28-Aug-2018	U54CA224079
sra	SRP166553	Clonal deletion of tumor-specific T cells by IFN-g confers therapeutic resistance to combination immune checkpoint blockade	PRJNA498104	23-Oct-2018	U01CA233100	30737146
sra	SRP166553	Clonal deletion of tumor-specific T cells by IFN-g confers therapeutic resistance to combination immune checkpoint blockade	PRJNA498104	23-Oct-2018	U01CA233100
sra	SRP159013	Gene exression in single T cells across division states.	PRJNA488249	28-Aug-2018	U24CA224309	30742126
sra	SRP159013	Gene exression in single T cells across division states.	PRJNA488249	28-Aug-2018	U24CA224309
sra	SRP108831	Genome-wide maps at the base-pair level, of chromatin regions enriched for H3 me3 marks in mouse glioma neurospheres (NS)	PRJNA389684	8-Jun-2017	U01CA224160	30760578
sra	SRP108831	Genome-wide maps at the base-pair level, of chromatin regions enriched for H3 me3 marks in mouse glioma neurospheres (NS)	PRJNA389684	8-Jun-2017	U01CA224160
sra	SRP100060	Differential gene expression in IDH1-R132H  Low Grade Glioma animal brain tumors brain in response to 10 Gy of radiation	PRJNA375076	16-Feb-2017	U01CA224160	30760578
sra	SRP100060	Differential gene expression in IDH1-R132H  Low Grade Glioma animal brain tumors brain in response to 10 Gy of radiation	PRJNA375076	16-Feb-2017	U01CA224160
sra	SRP158518	SOX2 epidermal overexpression promotes cutaneous wound healing via activation of EGFR/MEK/ERK signaling mediated by EGFR ligands	PRJNA487061	21-Aug-2018	R33CA225291	30772301
sra	SRP158518	SOX2 epidermal overexpression promotes cutaneous wound healing via activation of EGFR/MEK/ERK signaling mediated by EGFR ligands	PRJNA487061	21-Aug-2018	R33CA225291
sra	SRP147456	Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes	PRJNA471680	16-May-2018	R01CA188900	30791937
sra	SRP147456	Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes	PRJNA471680	16-May-2018	U24CA232979	30791937
sra	SRP147456	Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes	PRJNA471680	16-May-2018	R01CA188900
sra	SRP147456	Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes	PRJNA471680	16-May-2018	U24CA232979
sra	SRP173344	Nr4a transcription factors limit CAR-T cell function in solid tumors [RNA-Seq]	PRJNA509668	12-Dec-2018	U01DE028227	30814732
sra	SRP173344	Nr4a transcription factors limit CAR-T cell function in solid tumors [RNA-Seq]	PRJNA509668	12-Dec-2018	U01DE028227
sra	SRP183188	Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity	PRJNA477870	25-Jun-2018	U2CCA233195	30827681
sra	SRP183188	Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity	PRJNA477870	25-Jun-2018	U2CCA233195
sra	SRP162488	Regulatory T cell depletion promotes oncogenic Kras driven pancreatic tumorigenesis.	PRJNA492936	24-Sep-2018	U01CA224145	30827862
sra	SRP162488	Regulatory T cell depletion promotes oncogenic Kras driven pancreatic tumorigenesis.	PRJNA492936	24-Sep-2018	U01CA224145	31911451
sra	SRP162488	Regulatory T cell depletion promotes oncogenic Kras driven pancreatic tumorigenesis.	PRJNA492936	24-Sep-2018	U01CA224145
sra	SRP187956	Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer	PRJNA526217	8-Mar-2019	R01AI109294	30867218
sra	SRP187956	Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer	PRJNA526217	8-Mar-2019	R01AI109294
sra	SRP137885	The gene expression profiles of antigen-primed wildtype and Ddit3-/- CD8 Pmel T cells	PRJNA449089	6-Apr-2018	U01CA232758	30894532
sra	SRP137885	The gene expression profiles of antigen-primed wildtype and Ddit3-/- CD8 Pmel T cells	PRJNA449089	6-Apr-2018	U01CA232758
sra	SRP168621	Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1]	PRJNA505501	14-Nov-2018	U54CA231641	30899417
sra	SRP168621	Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1]	PRJNA505501	14-Nov-2018	U54CA231641
sra	SRP168620	Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 2]	PRJNA505502	14-Nov-2018	U54CA231641	30899417
sra	SRP168620	Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 2]	PRJNA505502	14-Nov-2018	U54CA231641
sra	SRP075249	PTEN-deficient synovial sarcoma	PRJNA321740	16-May-2016	U54CA231652	30909651
sra	SRP075249	PTEN-deficient synovial sarcoma	PRJNA321740	16-May-2016	U54CA231652
sra	SRP326507	Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer	PRJNA743059	1-Jul-2021	P50CA186786	30918020
sra	SRP326507	Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer	PRJNA743059	1-Jul-2021	P50CA186786
sra	SRP136023	Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li)	PRJNA438990	19-Mar-2018	U01CA233074	30923373
sra	SRP136023	Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li)	PRJNA438990	19-Mar-2018	U01CA233074
sra	SRP187083	Single cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species	PRJNA524857	28-Feb-2019	R01AI084880	30979687
sra	SRP187083	Single cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species	PRJNA524857	28-Feb-2019	R01AI084880
sra	SRP150094	Integrated transcriptomic and proteomic analysis of primary human umbilical vein endothelial cells	PRJNA475283	8-Jun-2018	U24CA210985	30983154
sra	SRP150094	Integrated transcriptomic and proteomic analysis of primary human umbilical vein endothelial cells	PRJNA475283	8-Jun-2018	U24CA210985
sra	SRP168173	PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP.	PRJNA504553	8-Nov-2018	P01CA154303	30988284
sra	SRP168173	PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP.	PRJNA504553	8-Nov-2018	P01CA154303
sra	SRP168172	PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO	PRJNA504554	8-Nov-2018	P01CA154303	30988284
sra	SRP168172	PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO	PRJNA504554	8-Nov-2018	P01CA154303
sra	SRP140872	PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO	PRJNA450797	18-Apr-2018	P01CA154303	30988284
sra	SRP140872	PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO	PRJNA450797	18-Apr-2018	P01CA154303
sra	SRP120172	Human CXCR5+CD45RA-CD8+ T cells subset in follicular lymphoma	PRJNA414624	17-Oct-2017	R01AI109294	31028278
sra	SRP120172	Human CXCR5+CD45RA-CD8+ T cells subset in follicular lymphoma	PRJNA414624	17-Oct-2017	R01AI109294
sra	SRP106891	Tumor microenvironment-activated angiotensin blockers enhance cancer immunotherapy	PRJNA386326	11-May-2017	R01CA208205	31040208
sra	SRP106891	Tumor microenvironment-activated angiotensin blockers enhance cancer immunotherapy	PRJNA386326	11-May-2017	R01CA208205
sra	SRP188564	CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy	PRJNA527311	15-Mar-2019	R01CA205426	31043744
sra	SRP188564	CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy	PRJNA527311	15-Mar-2019	R01CA205426
sra	SRP194099	Genome wide CRISPR screen for Venetoclax resisatnce in MOLM13 cells using Brunello library	PRJNA540212	29-Apr-2019	U54CA224019	31048320
sra	SRP194099	Genome wide CRISPR screen for Venetoclax resisatnce in MOLM13 cells using Brunello library	PRJNA540212	29-Apr-2019	U54CA224019
sra	SRP194098	Genome wide CRISPR screen for Venetoclax resisatnce in MOLM13 cells using Y. Kosuke library	PRJNA540211	29-Apr-2019	U54CA224019	31048320
sra	SRP194098	Genome wide CRISPR screen for Venetoclax resisatnce in MOLM13 cells using Y. Kosuke library	PRJNA540211	29-Apr-2019	U54CA224019
sra	SRP186687	Cancer Cell Line Encyclopedia (CCLE)	PRJNA523380	20-Feb-2019	P50CA098258	31068700
sra	SRP186687	Cancer Cell Line Encyclopedia (CCLE)	PRJNA523380	20-Feb-2019	U54CA224068	31068700
sra	SRP186687	Cancer Cell Line Encyclopedia (CCLE)	PRJNA523380	20-Feb-2019	P50CA098258
sra	SRP186687	Cancer Cell Line Encyclopedia (CCLE)	PRJNA523380	20-Feb-2019	U54CA224068
sra	SRP119053	Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia	PRJNA412479	28-Sep-2017	R01CA196658	31085557
sra	SRP119053	Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia	PRJNA412479	28-Sep-2017	R01CA196658
sra	SRP136009	Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks (ChIP-Seq)	PRJNA438961	19-Mar-2018	U01CA217885	31097695
sra	SRP136009	Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks (ChIP-Seq)	PRJNA438961	19-Mar-2018	U01CA217885
sra	SRP136016	A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers (RNA-Seq)	PRJNA438981	19-Mar-2018	U01CA217885	31097695
sra	SRP136016	A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers (RNA-Seq)	PRJNA438981	19-Mar-2018	U01CA217885
sra	SRP136011	A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers (MBD-Seq)	PRJNA438962	19-Mar-2018	U01CA217885	31097695
sra	SRP136011	A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers (MBD-Seq)	PRJNA438962	19-Mar-2018	U01CA217885
sra	SRP194361	Distruption of TOX and TOX2 transcription factors in CAR T cells limits T cell exhaustion [ATAC-Seq]	PRJNA540590	1-May-2019	U01DE028227	31152140
sra	SRP194361	Distruption of TOX and TOX2 transcription factors in CAR T cells limits T cell exhaustion [ATAC-Seq]	PRJNA540590	1-May-2019	U01DE028227
sra	SRP194360	Distruption of TOX and TOX2 transcription factors in CAR T cells limits T cell exhaustion [RNA-Seq]	PRJNA540585	1-May-2019	U01DE028227	31152140
sra	SRP194360	Distruption of TOX and TOX2 transcription factors in CAR T cells limits T cell exhaustion [RNA-Seq]	PRJNA540585	1-May-2019	U01DE028227
sra	SRP193759	Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231	PRJNA534487	24-Apr-2019	R21CA191179	31188523
sra	SRP193759	Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231	PRJNA534487	24-Apr-2019	R21CA191179
sra	SRP191615	Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals cancer-associated fibroblasts expressing MHC class II	PRJNA531464	8-Apr-2019	R33CA206949	31197017
sra	SRP191615	Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals cancer-associated fibroblasts expressing MHC class II	PRJNA531464	8-Apr-2019	R33CA206949
sra	SRP186683	Transcriptome analysis of various TOX+ and TOX- tumor-infiltrating CD8 T cells and in vitro TOX over-expressing T cells.	PRJNA523937	23-Feb-2019	R01AR070234	31207604
sra	SRP186683	Transcriptome analysis of various TOX+ and TOX- tumor-infiltrating CD8 T cells and in vitro TOX over-expressing T cells.	PRJNA523937	23-Feb-2019	R01AR070234
sra	SRP186681	ATACseq profiling of various TOX+ and TOX- tumor-infiltrating CD8 T cells	PRJNA523939	23-Feb-2019	R01AR070234	31207604
sra	SRP186681	ATACseq profiling of various TOX+ and TOX- tumor-infiltrating CD8 T cells	PRJNA523939	23-Feb-2019	R01AR070234
sra	SRP184654	KSDM1b Role in Ewing Sarcoma	PRJNA521471	8-Feb-2019	U54CA231641	31231465
sra	SRP184654	KSDM1b Role in Ewing Sarcoma	PRJNA521471	8-Feb-2019	U54CA231641
sra	SRP189472	Genomic analyses of primary mouse prostate organoid culture with overexpression of FOXA1	PRJNA529188	26-Mar-2019	U54CA224079	31243370
sra	SRP189472	Genomic analyses of primary mouse prostate organoid culture with overexpression of FOXA1	PRJNA529188	26-Mar-2019	U54CA224079
sra	SRP173277	Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq]	PRJNA509422	11-Dec-2018	P50CA186786	31243372
sra	SRP173277	Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq]	PRJNA509422	11-Dec-2018	P50CA186786
sra	SRP173276	Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [ChIP-Seq]	PRJNA509421	11-Dec-2018	P50CA186786	31243372
sra	SRP173276	Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [ChIP-Seq]	PRJNA509421	11-Dec-2018	P50CA186786
sra	SRP136603	Chromatin interaction of ERG and AR in established prostate cancer	PRJNA445955	28-Mar-2018	U54CA224079	31296553
sra	SRP136603	Chromatin interaction of ERG and AR in established prostate cancer	PRJNA445955	28-Mar-2018	U54CA224079
sra	SRP173943	Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells	PRJNA510812	19-Dec-2018	R01CA192914	31315653
sra	SRP173943	Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells	PRJNA510812	19-Dec-2018	R01CA192914
sra	SRP183532	Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer	PRJNA520923	4-Feb-2019	R37CA230617	31361600
sra	SRP183532	Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer	PRJNA520923	4-Feb-2019	R37CA230617
sra	SRP151006	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [ribosome profiling]	PRJNA476979	20-Jun-2018	R37CA230617	31366581
sra	SRP151006	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [ribosome profiling]	PRJNA476979	20-Jun-2018	U54CA224079	31366581
sra	SRP151006	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [ribosome profiling]	PRJNA476979	20-Jun-2018	R37CA230617
sra	SRP151006	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [ribosome profiling]	PRJNA476979	20-Jun-2018	U54CA224079
sra	SRP151005	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [RNA-seq]	PRJNA476980	20-Jun-2018	R37CA230617	31366581
sra	SRP151005	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [RNA-seq]	PRJNA476980	20-Jun-2018	U54CA224079	31366581
sra	SRP151005	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [RNA-seq]	PRJNA476980	20-Jun-2018	R37CA230617
sra	SRP151005	The androgen receptor regulates a druggable translational regulon in advanced prostate cancer [RNA-seq]	PRJNA476980	20-Jun-2018	U54CA224079
sra	SRP212736	Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16	PRJNA552100	1-Jul-2019	U54CA224070	31433975
sra	SRP212736	Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16	PRJNA552100	1-Jul-2019	U54CA224070
sra	SRP173457	MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells	PRJNA510078	14-Dec-2018	U01CA233084	31435022
sra	SRP173457	MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells	PRJNA510078	14-Dec-2018	U24CA232979	31435022
sra	SRP173457	MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells	PRJNA510078	14-Dec-2018	U01CA233084
sra	SRP173457	MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells	PRJNA510078	14-Dec-2018	U24CA232979
sra	SRP213899	Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet	PRJNA553549	9-Jul-2019	U54CA224068	31442404
sra	SRP213899	Ketone body signaling mediates intestinal stem cell homeostasis and adaptation to diet	PRJNA553549	9-Jul-2019	U54CA224068
sra	SRP167968	Genome-wide gene-expression profile of mouse intestinal stem cells/progenitors/Paneth cells	PRJNA504033	6-Nov-2018	U54CA224068	31442404
sra	SRP167968	Genome-wide gene-expression profile of mouse intestinal stem cells/progenitors/Paneth cells	PRJNA504033	6-Nov-2018	U54CA224068
sra	SRP168253	Single-cell profiling guided combinatorial immunotherapy for breast cancer resistance to Her2/neu and CDK4/6 targeted therapy	PRJNA504662	8-Nov-2018	U54CA209978	31444334
sra	SRP168253	Single-cell profiling guided combinatorial immunotherapy for breast cancer resistance to Her2/neu and CDK4/6 targeted therapy	PRJNA504662	8-Nov-2018	U54CA209978
sra	SRP171158	Mutationally-activated PI3'-kinase-a promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase	PRJNA507606	29-Nov-2018	R01CA131261	31452510
sra	SRP171158	Mutationally-activated PI3'-kinase-a promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase	PRJNA507606	29-Nov-2018	R01CA131261
sra	SRP186643	A lineage-resolved molecular atlas of C. elegans embryogenesis at single cell resolution	PRJNA523834	22-Feb-2019	U2CCA233285	31488706
sra	SRP186643	A lineage-resolved molecular atlas of C. elegans embryogenesis at single cell resolution	PRJNA523834	22-Feb-2019	U2CCA233285
sra	SRP134375	Deletion of Lats 1 and 2 in mouse pancreatic acinar cells	PRJNA437647	9-Mar-2018	U01CA224145	31513574
sra	SRP134375	Deletion of Lats 1 and 2 in mouse pancreatic acinar cells	PRJNA437647	9-Mar-2018	U01CA224145
sra	SRP218939	Next genereration sequencing reveals that CNAs associated with cyclin E overexpression tranlate into changes in transcriptional output.	PRJNA561187	20-Aug-2019	U01CA217885	31513970
sra	SRP218939	Next genereration sequencing reveals that CNAs associated with cyclin E overexpression tranlate into changes in transcriptional output.	PRJNA561187	20-Aug-2019	U01CA217885
sra	SRP214243	MUC1-C ACTIVATES THE NURD COMPLEX IN DEDIFFERENTIATION OF TRIPLE-NEGATIVE BREASTCANCER CELLS	PRJNA554094	11-Jul-2019	U01CA233084	31519689
sra	SRP214243	MUC1-C ACTIVATES THE NURD COMPLEX IN DEDIFFERENTIATION OF TRIPLE-NEGATIVE BREASTCANCER CELLS	PRJNA554094	11-Jul-2019	U24CA232979	31519689
sra	SRP214243	MUC1-C ACTIVATES THE NURD COMPLEX IN DEDIFFERENTIATION OF TRIPLE-NEGATIVE BREASTCANCER CELLS	PRJNA554094	11-Jul-2019	U01CA233084
sra	SRP214243	MUC1-C ACTIVATES THE NURD COMPLEX IN DEDIFFERENTIATION OF TRIPLE-NEGATIVE BREASTCANCER CELLS	PRJNA554094	11-Jul-2019	U24CA232979
sra	SRP217327	Napabucasin-mediated transcriptomic changes in human pancreatic cancer cell lines	PRJNA558548	4-Aug-2019	R33CA206949	31527169
sra	SRP217327	Napabucasin-mediated transcriptomic changes in human pancreatic cancer cell lines	PRJNA558548	4-Aug-2019	R33CA206949
sra	SRP215841	Identification of PIKfyve kinase as a target in multiple myeloma	PRJNA555832	22-Jul-2019	U54CA224018	31582538
sra	SRP215841	Identification of PIKfyve kinase as a target in multiple myeloma	PRJNA555832	22-Jul-2019	U54CA224018
sra	SRP218895	Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19	PRJNA561160	20-Aug-2019	P01CA214278	31591467
sra	SRP218895	Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19	PRJNA561160	20-Aug-2019	U01CA232563	31591467
sra	SRP218895	Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19	PRJNA561160	20-Aug-2019	P01CA214278
sra	SRP218895	Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19	PRJNA561160	20-Aug-2019	U01CA232563
sra	SRP121512	N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [MeRIP-seq]	PRJNA415689	24-Oct-2017	R37CA230617	31601799
sra	SRP121512	N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [MeRIP-seq]	PRJNA415689	24-Oct-2017	R37CA230617
sra	SRP217139	Lactate mediated epigenetic reprogramming during cancer associated fibroblast formation	PRJNA557889	1-Aug-2019	U24CA224020	31663852
sra	SRP217139	Lactate mediated epigenetic reprogramming during cancer associated fibroblast formation	PRJNA557889	1-Aug-2019	U24CA224020
sra	SRP188729	Papillomavirus-Colonized Murine Skin Confers Cancer Resistance	PRJNA527818	18-Mar-2019	U01CA233097	31666702
sra	SRP188729	Papillomavirus-Colonized Murine Skin Confers Cancer Resistance	PRJNA527818	18-Mar-2019	U01CA233097
sra	SRP186949	In vitro and in vivo epigenome-wide CRISPR screens in mouse KrasG12D/P53-/- (KP) lung adenocarcinoma model	PRJNA524379	26-Feb-2019	U01CA233084	31744829
sra	SRP186949	In vitro and in vivo epigenome-wide CRISPR screens in mouse KrasG12D/P53-/- (KP) lung adenocarcinoma model	PRJNA524379	26-Feb-2019	U01CA233084
sra	SRP224749	In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma	PRJNA576429	8-Oct-2019	U01CA233084	31744829
sra	SRP224749	In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma	PRJNA576429	8-Oct-2019	U01CA233084
sra	SRP212687	Single-cell transcriptomic profiling of mouse KrasG12DP53-/- (KP) lung tumors in response to tumor cell intrinsic Asf1a knockout (KO), anti-PD-1 or combination treatment (Asf1a KO + anti-PD-1).	PRJNA552032	1-Jul-2019	U01CA233084	31744829
sra	SRP212687	Single-cell transcriptomic profiling of mouse KrasG12DP53-/- (KP) lung tumors in response to tumor cell intrinsic Asf1a knockout (KO), anti-PD-1 or combination treatment (Asf1a KO + anti-PD-1).	PRJNA552032	1-Jul-2019	U01CA233084
sra	SRP224585	FBXW7 is a defining driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition	PRJNA576165	7-Oct-2019	R01CA211339	31772025
sra	SRP224585	FBXW7 is a defining driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition	PRJNA576165	7-Oct-2019	R01CA211339
sra	SRP214326	Single cell ATAC sequencing profile of quiescent mesenchymal progenitors	PRJNA554142	11-Jul-2019	U54CA231652	31809738
sra	SRP214326	Single cell ATAC sequencing profile of quiescent mesenchymal progenitors	PRJNA554142	11-Jul-2019	U54CA231652
sra	SRP213792	RNA-seq profiling of adult skeletal muscle after long term conditional knockout of Hic1 [TA RNA-seq]	PRJNA553290	8-Jul-2019	U54CA231652	31809738
sra	SRP213792	RNA-seq profiling of adult skeletal muscle after long term conditional knockout of Hic1 [TA RNA-seq]	PRJNA553290	8-Jul-2019	U54CA231652
sra	SRP132021	Single cell RNA sequencing time-course of mesenchymal progenitors during regeneration after notexin induced muscle injury	PRJNA432604	1-Feb-2018	U54CA231652	31809738
sra	SRP132021	Single cell RNA sequencing time-course of mesenchymal progenitors during regeneration after notexin induced muscle injury	PRJNA432604	1-Feb-2018	U54CA231652
sra	SRP222871	A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II]	PRJNA573462	21-Sep-2019	R01CA176745	31821784
sra	SRP222871	A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II]	PRJNA573462	21-Sep-2019	R01CA176745
sra	SRP222870	A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [Cut&amp;Run]	PRJNA573463	21-Sep-2019	R01CA176745	31821784
sra	SRP222870	A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [Cut&amp;Run]	PRJNA573463	21-Sep-2019	R01CA176745
sra	SRP187096	A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [ChIP-seq]	PRJNA524887	28-Feb-2019	R01CA176745	31821784
sra	SRP187096	A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [ChIP-seq]	PRJNA524887	28-Feb-2019	R01CA176745
sra	SRP220659	CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]	PRJNA564283	6-Sep-2019	R01CA221290	31827283
sra	SRP220659	CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]	PRJNA564283	6-Sep-2019	R01CA221290
sra	SRP220658	CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]	PRJNA564279	6-Sep-2019	R01CA221290	31827283
sra	SRP220658	CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]	PRJNA564279	6-Sep-2019	R01CA221290
sra	SRP183512	CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq]	PRJNA520909	4-Feb-2019	R01CA221290	31827283
sra	SRP183512	CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq]	PRJNA520909	4-Feb-2019	R01CA221290
sra	SRP198497	A large peptidome dataset improves HLA class I epitope prediction across most of the human population	PRJNA543098	15-May-2019	U24CA224331	31844290
sra	SRP198497	A large peptidome dataset improves HLA class I epitope prediction across most of the human population	PRJNA543098	15-May-2019	U24CA224331
sra	SRP126055	RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer	PRJNA420950	4-Dec-2017	R01CA124633	31883965
sra	SRP126055	RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer	PRJNA420950	4-Dec-2017	R01CA124633
sra	SRP222296	Transcriptomic profiling of mouse lung tumor cells in response to CDK7 inhibitor treatment	PRJNA566130	18-Sep-2019	P01CA154303	31883968
sra	SRP222296	Transcriptomic profiling of mouse lung tumor cells in response to CDK7 inhibitor treatment	PRJNA566130	18-Sep-2019	P01CA154303
sra	SRP190511	Single-cell transcriptomic profiling of mouse lung tumor in response to CDK7 inhibitor, anti-PD-1 and combination treatment (Experiment 2)	PRJNA530769	3-Apr-2019	P01CA154303	31883968
sra	SRP190511	Single-cell transcriptomic profiling of mouse lung tumor in response to CDK7 inhibitor, anti-PD-1 and combination treatment (Experiment 2)	PRJNA530769	3-Apr-2019	P01CA154303
sra	SRP055512	Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis	PRJNA276455	25-Feb-2015	R01CA207445	31907974
sra	SRP055512	Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis	PRJNA276455	25-Feb-2015	R01CA207445
sra	SRP301811	Regulatory T Cell depletion causes compensatory immune suppression and accelerated pancreatic carcinogenesis	PRJNA590272	18-Nov-2019	U01CA224145	31911451
sra	SRP301811	Regulatory T Cell depletion causes compensatory immune suppression and accelerated pancreatic carcinogenesis	PRJNA590272	18-Nov-2019	U01CA224145
sra	SRP189142	Regulatory T cell depletion causes compensatory immune suppression and accelerated pancreatic carcinogenesis.	PRJNA528597	22-Mar-2019	U01CA224145	31911451
sra	SRP189142	Regulatory T cell depletion causes compensatory immune suppression and accelerated pancreatic carcinogenesis.	PRJNA528597	22-Mar-2019	U01CA224145
sra	SRP156614	STRIPAK directs PP2A activity to promote oncogenic transformation	PRJNA485011	7-Aug-2018	U01CA217885	31913126
sra	SRP156614	STRIPAK directs PP2A activity to promote oncogenic transformation	PRJNA485011	7-Aug-2018	U01DE028227	31913126
sra	SRP156614	STRIPAK directs PP2A activity to promote oncogenic transformation	PRJNA485011	7-Aug-2018	U01CA217885
sra	SRP156614	STRIPAK directs PP2A activity to promote oncogenic transformation	PRJNA485011	7-Aug-2018	U01DE028227
sra	SRP222942	Androgen Receptor Degraders Overcome Common Resistance Mechanisms Developed During Prostate Cancer Treatment	PRJNA573618	23-Sep-2019	P50CA186786	31931431
sra	SRP222942	Androgen Receptor Degraders Overcome Common Resistance Mechanisms Developed During Prostate Cancer Treatment	PRJNA573618	23-Sep-2019	P50CA186786
sra	SRP218453	MYC and Twist1 Expression in Cancer Cells Activates Host Macrophages to Enable metastasis	PRJNA560393	15-Aug-2019	U01CA231776	31933479
sra	SRP218453	MYC and Twist1 Expression in Cancer Cells Activates Host Macrophages to Enable metastasis	PRJNA560393	15-Aug-2019	U01CA231776
sra	SRP225053	Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway [scRNASeq]	PRJNA576817	10-Oct-2019	P01CA154303	31935369
sra	SRP225053	Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway [scRNASeq]	PRJNA576817	10-Oct-2019	P01CA154303
sra	SRP199298	Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway [ChIP + ATAC]	PRJNA544436	23-May-2019	P01CA154303	31935369
sra	SRP199298	Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway [ChIP + ATAC]	PRJNA544436	23-May-2019	P01CA154303
sra	SRP226622	DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing	PRJNA578900	22-Oct-2019	P01CA210944	31937348
sra	SRP226622	DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing	PRJNA578900	22-Oct-2019	U2CCA233285	31937348
sra	SRP226622	DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing	PRJNA578900	22-Oct-2019	P01CA210944
sra	SRP226622	DENDRO: genetic heterogeneity profiling and subclone detection by single-cell RNA sequencing	PRJNA578900	22-Oct-2019	U2CCA233285
sra	SRP226833	MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer	PRJNA579338	24-Oct-2019	U01CA233084	31953400
sra	SRP226833	MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer	PRJNA579338	24-Oct-2019	U24CA232979	31953400
sra	SRP226833	MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer	PRJNA579338	24-Oct-2019	U01CA233084	34163028
sra	SRP226833	MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer	PRJNA579338	24-Oct-2019	U24CA232979	34163028
sra	SRP226833	MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer	PRJNA579338	24-Oct-2019	U01CA233084
sra	SRP226833	MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer	PRJNA579338	24-Oct-2019	U24CA232979
sra	SRP192022	MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1c mutations [RNA-Seq]	PRJNA532383	11-Apr-2019	R01CA176745	32001657
sra	SRP192022	MLL-Menin inhibition reverses pre-leukemic progenitor self-renewal induced by NPM1c mutations [RNA-Seq]	PRJNA532383	11-Apr-2019	R01CA176745
sra	SRP199773	ATAC-seq in ARID1A WT or KO OVCA429 Cells after interferron treatment	PRJNA545316	29-May-2019	P50CA186786	32027624
sra	SRP199773	ATAC-seq in ARID1A WT or KO OVCA429 Cells after interferron treatment	PRJNA545316	29-May-2019	P50CA186786
sra	SRP199772	Intersection of ARID1A, EZH2 RNA-seq in OVCA429 cells with IFN? treatment	PRJNA545317	29-May-2019	P50CA186786	32027624
sra	SRP199772	Intersection of ARID1A, EZH2 RNA-seq in OVCA429 cells with IFN? treatment	PRJNA545317	29-May-2019	P50CA186786
sra	SRP173553	The single cell transcriptional landscape of a mouse model of lung cancer metastasis	PRJNA510250	16-Dec-2018	U2CCA233284	32042191
sra	SRP173553	The single cell transcriptional landscape of a mouse model of lung cancer metastasis	PRJNA510250	16-Dec-2018	U2CCA233284
sra	SRP173552	The single cell transcriptional landscape of human lung adenocarcinoma (primary tumours and metastases)	PRJNA510251	16-Dec-2018	U2CCA233284	32042191
sra	SRP173552	The single cell transcriptional landscape of human lung adenocarcinoma (primary tumours and metastases)	PRJNA510251	16-Dec-2018	U2CCA233284
sra	SRP221282	Blockade of lL17 signaling reverses alcohol-induced liver injury, and excessive alcohol drinking in mice.	PRJNA564833	10-Sep-2019	U01AA027681	32051339
sra	SRP221282	Blockade of lL17 signaling reverses alcohol-induced liver injury, and excessive alcohol drinking in mice.	PRJNA564833	10-Sep-2019	U01AA027681
sra	SRP247892	Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability	PRJNA605702	10-Feb-2020	P01CA214278	32069268
sra	SRP247892	Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability	PRJNA605702	10-Feb-2020	P01CA214278
sra	SRP235221	The landscape of alternative splicing in aggressive prostate cancers	PRJNA594270	9-Dec-2019	U01CA233074	32086391
sra	SRP235221	The landscape of alternative splicing in aggressive prostate cancers	PRJNA594270	9-Dec-2019	U24CA232979	32086391
sra	SRP235221	The landscape of alternative splicing in aggressive prostate cancers	PRJNA594270	9-Dec-2019	U01CA233074
sra	SRP235221	The landscape of alternative splicing in aggressive prostate cancers	PRJNA594270	9-Dec-2019	U24CA232979
sra	SRP241924	Joint Profiling of Chromatin Accessibility and CAR-T Integration Site Analysis at Population and Single-cell Levels II	PRJNA601177	14-Jan-2020	P01CA214278	32094195
sra	SRP241924	Joint Profiling of Chromatin Accessibility and CAR-T Integration Site Analysis at Population and Single-cell Levels II	PRJNA601177	14-Jan-2020	P01CA214278
sra	SRP241923	Joint Profiling of Chromatin Accessibility and CAR-T Integration Site Analysis at Population and Single-cell Levels I	PRJNA601178	14-Jan-2020	P01CA214278	32094195
sra	SRP241923	Joint Profiling of Chromatin Accessibility and CAR-T Integration Site Analysis at Population and Single-cell Levels I	PRJNA601178	14-Jan-2020	P01CA214278
sra	SRP238470	Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer	PRJNA597127	21-Dec-2019	U54CA233223	32142667
sra	SRP238470	Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer	PRJNA597127	21-Dec-2019	U54CA233223
sra	SRP225104	TEAD1 and TEAD3 play redundant roles in human epidermal proliferation	PRJNA576911	10-Oct-2019	U01CA217885	32142794
sra	SRP225104	TEAD1 and TEAD3 play redundant roles in human epidermal proliferation	PRJNA576911	10-Oct-2019	U01CA217885
sra	SRP233583	An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers	PRJNA592199	27-Nov-2019	R01CA226776	32164626
sra	SRP233583	An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers	PRJNA592199	27-Nov-2019	R01CA226776
sra	SRP197106	H3K36 methyltransferase SETD2 regulates lymphoid and neural development [seq]	PRJNA541930	8-May-2019	R01CA176745	32169821
sra	SRP197106	H3K36 methyltransferase SETD2 regulates lymphoid and neural development [seq]	PRJNA541930	8-May-2019	R01CA176745
sra	SRP220733	Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element	PRJNA564340	6-Sep-2019	P50CA186786	32198885
sra	SRP220733	Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element	PRJNA564340	6-Sep-2019	P50CA186786
sra	SRP223942	MYCN and MYC ChIP-Seq profiling in neuroblastoma cell lines	PRJNA575351	2-Oct-2019	U54CA232568	32211329
sra	SRP223942	MYCN and MYC ChIP-Seq profiling in neuroblastoma cell lines	PRJNA575351	2-Oct-2019	U54CA232568
sra	SRP187768	Loss of CHD1 promotes chromatin dysregulation leading to heterogeneous mechanisms of resistance to hormone therapy in prostate cancer [shRNA screen]	PRJNA525865	6-Mar-2019	U54CA224079	32220301
sra	SRP187768	Loss of CHD1 promotes chromatin dysregulation leading to heterogeneous mechanisms of resistance to hormone therapy in prostate cancer [shRNA screen]	PRJNA525865	6-Mar-2019	U54CA224079
sra	SRP230212	Discovery of a selective inhibitor of Doublecortin Like Kinase 1	PRJNA589887	15-Nov-2019	U01CA224146	32251410
sra	SRP230212	Discovery of a selective inhibitor of Doublecortin Like Kinase 1	PRJNA589887	15-Nov-2019	U01CA224146
sra	SRP243832	Whole genome sequencing of bulk and single RPE-1 cells with induced chromosomal instability	PRJNA602546	21-Jan-2020	R33CA225344	32299917
sra	SRP243832	Whole genome sequencing of bulk and single RPE-1 cells with induced chromosomal instability	PRJNA602546	21-Jan-2020	R33CA225344
sra	SRP252454	High Throughput pMHC-I Tetramer Library Production Using Chaperone Mediated Peptide Exchange	PRJNA612056	11-Mar-2020	U54CA232568	32312993
sra	SRP252454	High Throughput pMHC-I Tetramer Library Production Using Chaperone Mediated Peptide Exchange	PRJNA612056	11-Mar-2020	U54CA232568
sra	SRP164390	Genome-wide survey of adjacent gene rearrangements in breast cancer identifies triple-negative specific BCL2L14-ETV6 fusions	PRJNA495013	8-Oct-2018	U54CA224076	32321829
sra	SRP164390	Genome-wide survey of adjacent gene rearrangements in breast cancer identifies triple-negative specific BCL2L14-ETV6 fusions	PRJNA495013	8-Oct-2018	U54CA224076
sra	SRP260906	scRNAseq of CD45+ cells within PDAC tumors treateted with CD40/ICB	PRJNA631402	9-May-2020	P01CA210944	32324594
sra	SRP260906	scRNAseq of CD45+ cells within PDAC tumors treateted with CD40/ICB	PRJNA631402	9-May-2020	P01CA210944
sra	SRP256482	Differential gene expression in mACVR1 NS v wt-ACVR1 NS.	PRJNA625523	15-Apr-2020	U01CA224160	32332014
sra	SRP256482	Differential gene expression in mACVR1 NS v wt-ACVR1 NS.	PRJNA625523	15-Apr-2020	U01CA224160
sra	SRP200058	Systematic comparative analysis of single cell RNA-sequencing methods	PRJNA545730	31-May-2019	U2CCA233195	32341560
sra	SRP200058	Systematic comparative analysis of single cell RNA-sequencing methods	PRJNA545730	31-May-2019	U2CCA233195
sra	SRP228608	Impact of splicing factors (ESRP1 and KHDRBS3) on prostate cancer biology	PRJNA587741	5-Nov-2019	U24CA232979	32350277
sra	SRP228608	Impact of splicing factors (ESRP1 and KHDRBS3) on prostate cancer biology	PRJNA587741	5-Nov-2019	U24CA232979
sra	SRP188817	Therapeutic targeting of splicing in aggressive prostate cancer	PRJNA527978	19-Mar-2019	U24CA232979	32350277
sra	SRP188817	Therapeutic targeting of splicing in aggressive prostate cancer	PRJNA527978	19-Mar-2019	U24CA232979
sra	SRP242206	Gene expression in DCIS.COM with BCL9 knockdown	PRJNA601728	16-Jan-2020	R01CA207445	32352029
sra	SRP242206	Gene expression in DCIS.COM with BCL9 knockdown	PRJNA601728	16-Jan-2020	R01CA207445
sra	SRP240551	BCL9/STAT3 Regulation of Transcriptional Enhancer Networks Promote DCIS Progression	PRJNA599998	8-Jan-2020	R01CA207445	32352029
sra	SRP240551	BCL9/STAT3 Regulation of Transcriptional Enhancer Networks Promote DCIS Progression	PRJNA599998	8-Jan-2020	R01CA207445
sra	SRP256199	Differentiated prostate luminal cells acquire enhanced regenerative potential after androgen ablation	PRJNA625051	11-Mar-2020	U54CA224079	32355025
sra	SRP256199	Differentiated prostate luminal cells acquire enhanced regenerative potential after androgen ablation	PRJNA625051	11-Mar-2020	U54CA224079
sra	SRP238472	Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734	PRJNA597130	21-Dec-2019	R01CA124633	32371576
sra	SRP238472	Combined targeting of the BRD4-NUT-p300 axis in NUT midline carcinoma by dual selective bromodomain inhibitor, NEO2734	PRJNA597130	21-Dec-2019	R01CA124633
sra	SRP226854	Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis	PRJNA579352	24-Oct-2019	U54CA224079	32376773
sra	SRP226854	Somatic tissue engineering in mouse models reveals an actionable role for WNT pathway alterations in prostate cancer metastasis	PRJNA579352	24-Oct-2019	U54CA224079
sra	SRP255477	Clinically-relevant cell type cross-talk identified from a lung tumor microenvironment interactome	PRJNA438518	15-Mar-2018	U24CA224309	32381040
sra	SRP255477	Clinically-relevant cell type cross-talk identified from a lung tumor microenvironment interactome	PRJNA438518	15-Mar-2018	U24CA224309
sra	SRP257861	“Direct to Drug” screening as a precision medicine tool in multiple myeloma	PRJNA627346	15-Apr-2020	U54CA224018	32393731
sra	SRP257861	“Direct to Drug” screening as a precision medicine tool in multiple myeloma	PRJNA627346	15-Apr-2020	U54CA224018
sra	SRP260068	Transcriptional landscape of four exhausted CD8 T cell subsets	PRJNA630424	5-May-2020	P01CA210944	32396847
sra	SRP260068	Transcriptional landscape of four exhausted CD8 T cell subsets	PRJNA630424	5-May-2020	P01CA210944
sra	SRP260066	Epigenetic landscape of four exhausted CD8 T cell subsets	PRJNA630423	5-May-2020	P01CA210944	32396847
sra	SRP260066	Epigenetic landscape of four exhausted CD8 T cell subsets	PRJNA630423	5-May-2020	P01CA210944
sra	SRP200090	Alternative splicing of LSD1+8a is mediated by SRRM4 in Neuroendocrine Prostate Cancer	PRJNA545801	1-Jun-2019	P50CA186786	32403054
sra	SRP200090	Alternative splicing of LSD1+8a is mediated by SRRM4 in Neuroendocrine Prostate Cancer	PRJNA545801	1-Jun-2019	P50CA186786
sra	SRP185483	Peri-pancreatic LN cDC1 KPC	PRJNA521746	11-Feb-2019	P01CA210944	32453421
sra	SRP185483	Peri-pancreatic LN cDC1 KPC	PRJNA521746	11-Feb-2019	P01CA210944
sra	SRP185482	Inguinal LN cDC1 SubQ KPC	PRJNA521744	11-Feb-2019	P01CA210944	32453421
sra	SRP185482	Inguinal LN cDC1 SubQ KPC	PRJNA521744	11-Feb-2019	P01CA210944
sra	SRP167882	CEBPA Dysfunction Intiates CSF3R Mutant Acute Myeloid Leukemia Through Disruption of Myeloid Lineage Enhancers (RNA-seq - simultaneous)	PRJNA503880	5-Nov-2018	U54CA224019	32471953
sra	SRP167882	CEBPA Dysfunction Intiates CSF3R Mutant Acute Myeloid Leukemia Through Disruption of Myeloid Lineage Enhancers (RNA-seq - simultaneous)	PRJNA503880	5-Nov-2018	U54CA224019
sra	SRP167881	CEBPA Dysfunction Intiates CSF3R Mutant Acute Myeloid Leukemia Through Disruption of Myeloid Lineage Enhancers (RNA-seq - orders)	PRJNA503881	5-Nov-2018	U54CA224019	32471953
sra	SRP167881	CEBPA Dysfunction Intiates CSF3R Mutant Acute Myeloid Leukemia Through Disruption of Myeloid Lineage Enhancers (RNA-seq - orders)	PRJNA503881	5-Nov-2018	U54CA224019
sra	SRP201753	The major pre- and post-menopausal estrogens play opposing roles in obesity driven mammary inflammation and breast cancer development	PRJNA549449	18-Jun-2019	R01CA210440	32492394
sra	SRP201753	The major pre- and post-menopausal estrogens play opposing roles in obesity driven mammary inflammation and breast cancer development	PRJNA549449	18-Jun-2019	R01CA210440
sra	SRP254656	Comparison of mRNA profiles of AGO2 sufficent and deficient pancreatic tissue in the LSL KRASG12D mouse model of pancreatic cancer	PRJNA616355	30-Mar-2020	U01CA224145	32499547
sra	SRP254656	Comparison of mRNA profiles of AGO2 sufficent and deficient pancreatic tissue in the LSL KRASG12D mouse model of pancreatic cancer	PRJNA616355	30-Mar-2020	U01CA224145
sra	SRP230181	Single Cell Analysis Reveals NUPR1 Promotes Docetaxel Resistance in Prostate Cancer	PRJNA589746	15-Nov-2019	P50CA186786	32513898
sra	SRP230181	Single Cell Analysis Reveals NUPR1 Promotes Docetaxel Resistance in Prostate Cancer	PRJNA589746	15-Nov-2019	P50CA186786
sra	SRP186092	Epidermal basal cell-specific in vivo ribosome profiling to describe the translation landscape of HrasG12V and Eif2b5	PRJNA522866	16-Feb-2019	R37CA230617	32516567
sra	SRP186092	Epidermal basal cell-specific in vivo ribosome profiling to describe the translation landscape of HrasG12V and Eif2b5	PRJNA522866	16-Feb-2019	R37CA230617
sra	SRP189732	Inter-myeloid cell synaptic antigen dispersal drives diversified anti-tumor T cell priming	PRJNA529639	28-Mar-2019	R01CA197363	32516589
sra	SRP189732	Inter-myeloid cell synaptic antigen dispersal drives diversified anti-tumor T cell priming	PRJNA529639	28-Mar-2019	R01CA197363
sra	SRP260821	Quantitative Analysis of Wild Type and CISH-/- induced pluripotent stem cell derived NK cells (iPSC-NK) Transcriptomes	PRJNA631264	8-May-2020	U01CA217885	32531207
sra	SRP260821	Quantitative Analysis of Wild Type and CISH-/- induced pluripotent stem cell derived NK cells (iPSC-NK) Transcriptomes	PRJNA631264	8-May-2020	U01CA217885
sra	SRP243450	Transcriptional profiling of ribociclib-treated sensitive and ribociclib resistant CAMA-1 cells	PRJNA602306	20-Jan-2020	U54CA209978	32565737
sra	SRP243450	Transcriptional profiling of ribociclib-treated sensitive and ribociclib resistant CAMA-1 cells	PRJNA602306	20-Jan-2020	U54CA209978
sra	SRP193372	Signaling state and abundance of circulating immune cell subpopulations determine cancer response to immunotherapy	PRJNA534106	22-Apr-2019	U54CA209978	32571915
sra	SRP193372	Signaling state and abundance of circulating immune cell subpopulations determine cancer response to immunotherapy	PRJNA534106	22-Apr-2019	U54CA209978
sra	SRP255945	Transcriptomic analysis of IRAK4 in murine pancreatic cancer cells (KP2)	PRJNA624277	10-Apr-2020	U54CA224083	32573499
sra	SRP255945	Transcriptomic analysis of IRAK4 in murine pancreatic cancer cells (KP2)	PRJNA624277	10-Apr-2020	U54CA224083
sra	SRP258057	Novel Inhibitors of the Histone-Methyltransferase DOT1L Show Potent Antileukemic Activity in Patient-derived Xenografts (RNA-seq dataset)	PRJNA627611	23-Apr-2020	R01CA176745	32575123
sra	SRP258057	Novel Inhibitors of the Histone-Methyltransferase DOT1L Show Potent Antileukemic Activity in Patient-derived Xenografts (RNA-seq dataset)	PRJNA627611	23-Apr-2020	R01CA176745
sra	SRP265179	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [WES]	PRJNA603106	24-Jan-2020	U2CCA233195	32579974
sra	SRP265179	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [WES]	PRJNA603106	24-Jan-2020	U2CCA233238	32579974
sra	SRP265179	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [WES]	PRJNA603106	24-Jan-2020	U2CCA233195
sra	SRP265179	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [WES]	PRJNA603106	24-Jan-2020	U2CCA233238
sra	SRP244706	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [single-cell RNA-seq]	PRJNA603103	24-Jan-2020	U2CCA233195	32579974
sra	SRP244706	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [single-cell RNA-seq]	PRJNA603103	24-Jan-2020	U2CCA233238	32579974
sra	SRP244706	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [single-cell RNA-seq]	PRJNA603103	24-Jan-2020	U2CCA233195
sra	SRP244706	Single Cell and Spatial Analysis of Human Squamous Cell Carcinoma [single-cell RNA-seq]	PRJNA603103	24-Jan-2020	U2CCA233238
sra	SRP253678	Functional characterization of the novel GWAS-identified GP2 coding variant	PRJNA614018	23-Mar-2020	U01CA164973	32581250
sra	SRP253678	Functional characterization of the novel GWAS-identified GP2 coding variant	PRJNA614018	23-Mar-2020	U01CA164973
sra	SRP251986	IL-18BP is a secreted immune checkpoint and barrier to effective IL-18 immunotherapy	PRJNA611084	8-Mar-2020	U01CA233096	32581358
sra	SRP251986	IL-18BP is a secreted immune checkpoint and barrier to effective IL-18 immunotherapy	PRJNA611084	8-Mar-2020	U01CA233096
sra	SRP250163	Recapitulation of Prostate Tissue Cell Type-specific Transcriptomes by an in vivo Primary Prostate Tissue Xenograft Model	PRJNA607784	20-Feb-2020	U24CA232979	32584883
sra	SRP250163	Recapitulation of Prostate Tissue Cell Type-specific Transcriptomes by an in vivo Primary Prostate Tissue Xenograft Model	PRJNA607784	20-Feb-2020	U24CA232979
sra	SRP249916	ZipSeq : Barcoding for Real-time Mapping of Single Cell Transcriptomes	PRJNA607323	18-Feb-2020	R01CA197363	32632238
sra	SRP249916	ZipSeq : Barcoding for Real-time Mapping of Single Cell Transcriptomes	PRJNA607323	18-Feb-2020	R01CA197363
sra	SRP212657	RNA seq to compare gene expression profiles between Npm1 WT and Npm1 knockdown cells	PRJNA551883	30-Jun-2019	P01CA154303	32646968
sra	SRP212657	RNA seq to compare gene expression profiles between Npm1 WT and Npm1 knockdown cells	PRJNA551883	30-Jun-2019	P01CA154303
sra	SRP265314	Neuropilin-1(NRP1) is a T cell memory checkpoint limiting long-term anti-tumor immunity	PRJNA635953	29-May-2020	P01CA210944	32661362
sra	SRP265314	Neuropilin-1(NRP1) is a T cell memory checkpoint limiting long-term anti-tumor immunity	PRJNA635953	29-May-2020	P01CA210944
sra	SRP269098	The Tumor Microenvironment and Inflammation Influence toxicity in patients with Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel [RNA-Seq]	PRJNA642648	28-Jun-2020	U01CA247576	32669372
sra	SRP269098	The Tumor Microenvironment and Inflammation Influence toxicity in patients with Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel [RNA-Seq]	PRJNA642648	28-Jun-2020	U01CA247576
sra	SRP246236	Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis [Cut&amp;Run ChIP-seq]	PRJNA604071	30-Jan-2020	U54CA243125	32675324
sra	SRP246236	Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis [Cut&amp;Run ChIP-seq]	PRJNA604071	30-Jan-2020	U54CA243125
sra	SRP261871	Single-cell atlas of human leptomeningeal metastasis	PRJNA633130	15-May-2020	U2CCA233284	32675368
sra	SRP261871	Single-cell atlas of human leptomeningeal metastasis	PRJNA633130	15-May-2020	U2CCA233284
sra	SRP247504	Leptomeningeal metastatic cells outcompete macrophages for iron through Lipocalin-2	PRJNA605149	6-Feb-2020	U2CCA233284	32675368
sra	SRP247504	Leptomeningeal metastatic cells outcompete macrophages for iron through Lipocalin-2	PRJNA605149	6-Feb-2020	U2CCA233284
sra	SRP255006	RNA-seq analysis in NRG1 and enzalutamide treated 22Pc-EP cell line	PRJNA622705	2-Apr-2020	U54CA224079	32679108
sra	SRP255006	RNA-seq analysis in NRG1 and enzalutamide treated 22Pc-EP cell line	PRJNA622705	2-Apr-2020	U54CA224079
sra	SRP153070	M1hot tumour associated macrophages are positively associated with tissue-resident memory T cell responses and survival outcomes in human lung cancer (single cells).	PRJNA480671	11-Jul-2018	U01CA224766	32699181
sra	SRP153070	M1hot tumour associated macrophages are positively associated with tissue-resident memory T cell responses and survival outcomes in human lung cancer (single cells).	PRJNA480671	11-Jul-2018	U01CA224766
sra	SRP153069	M1hot tumour associated macrophages are positively associated with tissue-resident memory T cell responses and survival outcomes in human lung cancer (bulk).	PRJNA480670	11-Jul-2018	U01CA224766	32699181
sra	SRP153069	M1hot tumour associated macrophages are positively associated with tissue-resident memory T cell responses and survival outcomes in human lung cancer (bulk).	PRJNA480670	11-Jul-2018	U01CA224766
sra	SRP266023	Multi-omics analysis reveals divergent epigenetic regulation of gene expression and drivers of esophageal squamous cell carcinoma [ChIP-seq]	PRJNA637386	4-Jun-2020	U54CA224081	32699215
sra	SRP266023	Multi-omics analysis reveals divergent epigenetic regulation of gene expression and drivers of esophageal squamous cell carcinoma [ChIP-seq]	PRJNA637386	4-Jun-2020	U54CA224081
sra	SRP259644	Multi-omics analysis reveals divergent epigenetic regulation of gene expression and drivers of esophageal squamous cell carcinoma	PRJNA630082	3-May-2020	U54CA224081	32699215
sra	SRP259644	Multi-omics analysis reveals divergent epigenetic regulation of gene expression and drivers of esophageal squamous cell carcinoma	PRJNA630082	3-May-2020	U54CA224081
sra	SRP259187	Multi-omics analysis reveals divergent epigenetic regulation of gene expression and drivers of esophageal squamous cell carcinoma (RNA-Seq)	PRJNA629358	29-Apr-2020	U54CA224081	32699215
sra	SRP259187	Multi-omics analysis reveals divergent epigenetic regulation of gene expression and drivers of esophageal squamous cell carcinoma (RNA-Seq)	PRJNA629358	29-Apr-2020	U54CA224081
sra	SRP266202	Differential expression of endogenous retroelements (long terminal repeats) in ADA2 depleted primary endothelial cells (HUVECs)	PRJNA637655	5-Jun-2020	U01DE028227	32743071
sra	SRP266202	Differential expression of endogenous retroelements (long terminal repeats) in ADA2 depleted primary endothelial cells (HUVECs)	PRJNA637655	5-Jun-2020	U01DE028227
sra	SRP261562	Tanscriptional profile of primary endothelial cells (HUVEC) in ADA2 depleted setting and effect of Dipyridamole (DPM) treatment	PRJNA632723	14-May-2020	U01DE028227	32743071
sra	SRP261562	Tanscriptional profile of primary endothelial cells (HUVEC) in ADA2 depleted setting and effect of Dipyridamole (DPM) treatment	PRJNA632723	14-May-2020	U01DE028227
sra	SRP226107	A bifunctional nucleosome binding protein mediates specialized mSWI/SNF complex targeting and activity (RNA-seq dataset)	PRJNA578158	17-Oct-2019	U54CA231638	32747783
sra	SRP226107	A bifunctional nucleosome binding protein mediates specialized mSWI/SNF complex targeting and activity (RNA-seq dataset)	PRJNA578158	17-Oct-2019	U54CA231638
sra	SRP268823	Identification of a CD117+? ?CD71+? ? early ?unipotent? neutrophil progenitor population in human bone marrow	PRJNA641887	25-Jun-2020	U01CA224766	32814027
sra	SRP268823	Identification of a CD117+? ?CD71+? ? early ?unipotent? neutrophil progenitor population in human bone marrow	PRJNA641887	25-Jun-2020	U01CA224766
sra	SRP246912	Chromatin profiling of the relationship between EWS/FLI, LSD1, and K27ac in multiple Ewing sarcoma cell lines	PRJNA604586	3-Feb-2020	U54CA231641	32842875
sra	SRP246912	Chromatin profiling of the relationship between EWS/FLI, LSD1, and K27ac in multiple Ewing sarcoma cell lines	PRJNA604586	3-Feb-2020	U54CA231641
sra	SRP269753	Genome-scale CRISPR-Cas9 knockout screening for identification of genes which regulate CD38 expression in RPMI 8226 cells	PRJNA643779	2-Jul-2020	P01CA155258	32844992
sra	SRP269753	Genome-scale CRISPR-Cas9 knockout screening for identification of genes which regulate CD38 expression in RPMI 8226 cells	PRJNA643779	2-Jul-2020	P01CA155258
sra	SRP271143	Multivalent proteins rapidly and reversibly phase-separate upon osmotic cell volume  change	PRJNA645164	9-Jul-2020	P50CA186786	32857953
sra	SRP271143	Multivalent proteins rapidly and reversibly phase-separate upon osmotic cell volume  change	PRJNA645164	9-Jul-2020	P50CA186786
sra	SRP266970	Effect of bone marrow microenvironment on the sensitivity of breast cancer cells to antiestrogens	PRJNA638946	11-Jun-2020	U54CA224079	32859606
sra	SRP266970	Effect of bone marrow microenvironment on the sensitivity of breast cancer cells to antiestrogens	PRJNA638946	11-Jun-2020	U54CA233223	32859606
sra	SRP266970	Effect of bone marrow microenvironment on the sensitivity of breast cancer cells to antiestrogens	PRJNA638946	11-Jun-2020	U54CA224079
sra	SRP266970	Effect of bone marrow microenvironment on the sensitivity of breast cancer cells to antiestrogens	PRJNA638946	11-Jun-2020	U54CA233223
sra	SRP236894	Massively parallel and time-resolved RNA sequencing in single cells with scNT-Seq	PRJNA594978	11-Dec-2019	U2CCA233285	32868927
sra	SRP236894	Massively parallel and time-resolved RNA sequencing in single cells with scNT-Seq	PRJNA594978	11-Dec-2019	U2CCA233285
sra	SRP257960	The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice	PRJNA627490	22-Apr-2020	U01CA224145	32882403
sra	SRP257960	The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice	PRJNA627490	22-Apr-2020	U01CA224145
sra	SRP275628	A Non-genetic Mechanism Involving the Integrin b4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer	PRJNA650468	3-Aug-2020	U54CA209978	32947124
sra	SRP275628	A Non-genetic Mechanism Involving the Integrin b4/Paxillin Axis Contributes to Chemoresistance in Lung Cancer	PRJNA650468	3-Aug-2020	U54CA209978
sra	SRP273011	Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s	PRJNA647616	22-Jul-2020	U24CA232979	33110069
sra	SRP273011	Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s	PRJNA647616	22-Jul-2020	U24CA232979
sra	SRP275646	Role of PTEN in B-ALL	PRJNA650503	3-Aug-2020	U01CA232563	33149299
sra	SRP275646	Role of PTEN in B-ALL	PRJNA650503	3-Aug-2020	U01CA232563
sra	SRP273997	An Ifitm3-dependent amplification loop enables antibody responses and oncogenic signaling in B-cells	PRJNA649275	28-Jul-2020	U01CA232563	33149299
sra	SRP273997	An Ifitm3-dependent amplification loop enables antibody responses and oncogenic signaling in B-cells	PRJNA649275	28-Jul-2020	U01CA232563
sra	SRP285920	Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer [CRISPR Screen]	PRJNA666653	30-Sep-2020	U01CA224146	33152323
sra	SRP285920	Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer [CRISPR Screen]	PRJNA666653	30-Sep-2020	U01CA224146
sra	SRP285919	Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer [RNA-Seq]	PRJNA666652	28-Sep-2020	U01CA224146	33152323
sra	SRP285919	Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer [RNA-Seq]	PRJNA666652	28-Sep-2020	U01CA224146
sra	SRP279024	ChIP-seq profiling of pancreatic tumor cells	PRJNA659482	26-Aug-2020	U54CA232568	33158848
sra	SRP279024	ChIP-seq profiling of pancreatic tumor cells	PRJNA659482	26-Aug-2020	U54CA232568
sra	SRP237758	Genome-wide maps of macroH2A and H2B distribution in murine embryonic fibroblasts in dependence of Lsh.	PRJNA595882	16-Dec-2019	R01CA163915	33159050
sra	SRP237758	Genome-wide maps of macroH2A and H2B distribution in murine embryonic fibroblasts in dependence of Lsh.	PRJNA595882	16-Dec-2019	R01CA163915
sra	SRP262218	Quantitative Analysis of different NK cell types Transcriptomes	PRJNA633630	18-May-2020	U01CA217885	33178188
sra	SRP262218	Quantitative Analysis of different NK cell types Transcriptomes	PRJNA633630	18-May-2020	U01CA217885
sra	SRP261255	Quantitative Analysis of different NK cell types Transcriptomes	PRJNA631914	12-May-2020	U01CA217885	33178188
sra	SRP261255	Quantitative Analysis of different NK cell types Transcriptomes	PRJNA631914	12-May-2020	U01CA217885
sra	SRP233500	PD-1 and TIGIT co-expression identifies a circulating CD8 T cell population predictive of response to anti-PD-1 therapy in melanoma and Merkel-cell carcinoma patients [RNA-seq]	PRJNA592169	27-Nov-2019	UM1CA154967	33188038
sra	SRP233500	PD-1 and TIGIT co-expression identifies a circulating CD8 T cell population predictive of response to anti-PD-1 therapy in melanoma and Merkel-cell carcinoma patients [RNA-seq]	PRJNA592169	27-Nov-2019	UM1CA154967
sra	SRP286166	Protein prenylation drives discrete signaling programs for the differentiation and maintenance of effector Treg cells [Pggt1b_ATACseq]	PRJNA667026	2-Oct-2020	R01CA221290	33207246
sra	SRP286166	Protein prenylation drives discrete signaling programs for the differentiation and maintenance of effector Treg cells [Pggt1b_ATACseq]	PRJNA667026	2-Oct-2020	R01CA221290
sra	SRP286175	Protein prenylation drives discrete signaling programs for the differentiation and maintenance of effector Treg cells [Fntb_ATACseq]	PRJNA667029	2-Oct-2020	R01CA221290	33207246
sra	SRP286175	Protein prenylation drives discrete signaling programs for the differentiation and maintenance of effector Treg cells [Fntb_ATACseq]	PRJNA667029	2-Oct-2020	R01CA221290
sra	SRP119365	Transcriptional Signaling Centers Regulate Erythroid Gene Expression and are Disrupted in Common Variations of Human Red Blood Cell Traits	PRJNA413084	3-Oct-2017	P01CA155258	33230299
sra	SRP119365	Transcriptional Signaling Centers Regulate Erythroid Gene Expression and are Disrupted in Common Variations of Human Red Blood Cell Traits	PRJNA413084	3-Oct-2017	P01CA155258
sra	SRP065489	BMP signaling cooperates with GATA factors to govern stage-specific gene expression during erythroid differentiation [ChIP-Seq]	PRJNA300539	29-Oct-2015	P01CA155258	33230299
sra	SRP065489	BMP signaling cooperates with GATA factors to govern stage-specific gene expression during erythroid differentiation [ChIP-Seq]	PRJNA300539	29-Oct-2015	P01CA155258
sra	SRP279627	Macrophage Gene Expression in PyMT Tumor Progression	PRJNA660767	1-Sep-2020	R01CA192914	33257795
sra	SRP279627	Macrophage Gene Expression in PyMT Tumor Progression	PRJNA660767	1-Sep-2020	R01CA192914
sra	SRP288281	Single Cell RNAseq on Renal adenocarcinoma	PRJNA670875	23-Oct-2020	R01CA197363	33264598
sra	SRP288281	Single Cell RNAseq on Renal adenocarcinoma	PRJNA670875	23-Oct-2020	R01CA197363
sra	SRP269226	Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving accumulation of glucose 6-phosphate	PRJNA642855	29-Jun-2020	U54CA224076	33292639
sra	SRP269226	Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving accumulation of glucose 6-phosphate	PRJNA642855	29-Jun-2020	U54CA224076
sra	SRP255872	RNA-Seq of brain metastatic breast cancer cell lines after knockout of lipid metabolism genes using CRISPR/Cas9 gene editing	PRJNA624099	9-Apr-2020	R01CA208205	33299191
sra	SRP255872	RNA-Seq of brain metastatic breast cancer cell lines after knockout of lipid metabolism genes using CRISPR/Cas9 gene editing	PRJNA624099	9-Apr-2020	R01CA208205
sra	SRP287552	Targeting Transcriptional Regulation of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2	PRJNA669811	19-Oct-2020	P50CA186786	33310900
sra	SRP287552	Targeting Transcriptional Regulation of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2	PRJNA669811	19-Oct-2020	P50CA186786
sra	SRP288305	Droplet based mRNA sequencing of fixed and permeabilized cells by CLInt-Seq allows for antigen specific TCR cloning	PRJNA670907	23-Oct-2020	U01CA233074	33431692
sra	SRP288305	Droplet based mRNA sequencing of fixed and permeabilized cells by CLInt-Seq allows for antigen specific TCR cloning	PRJNA670907	23-Oct-2020	U01CA233074
sra	SRP285135	Targeted single-cell RNAseq of tonsil organoid cultures	PRJNA665262	23-Sep-2020	U54CA224081	33432170
sra	SRP285135	Targeted single-cell RNAseq of tonsil organoid cultures	PRJNA665262	23-Sep-2020	U54CA224081
sra	SRP292343	Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. [RNA-Seq]	PRJNA677942	12-Nov-2020	U54CA224070	33436641
sra	SRP292343	Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. [RNA-Seq]	PRJNA677942	12-Nov-2020	U54CA224070
sra	SRP291283	Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. [TCR]	PRJNA674781	5-Nov-2020	U54CA224070	33436641
sra	SRP291283	Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. [TCR]	PRJNA674781	5-Nov-2020	U54CA224070
sra	SRP243766	Genomic alterations during the in situ to invasive ductal breast carcinoma transition shaped by the immune system	PRJNA602512	21-Jan-2020	U24CA224331	33443130
sra	SRP243766	Genomic alterations during the in situ to invasive ductal breast carcinoma transition shaped by the immune system	PRJNA602512	21-Jan-2020	U24CA224331
sra	SRP300174	A CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and non-essential modes of oncogenic transformation	PRJNA689437	4-Jan-2021	R01CA163915	33451982
sra	SRP300174	A CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and non-essential modes of oncogenic transformation	PRJNA689437	4-Jan-2021	U54CA224081	33451982
sra	SRP300174	A CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and non-essential modes of oncogenic transformation	PRJNA689437	4-Jan-2021	R01CA163915
sra	SRP300174	A CRISPR/Cas9-engineered ARID1A-deficient human gastric cancer organoid model reveals essential and non-essential modes of oncogenic transformation	PRJNA689437	4-Jan-2021	U54CA224081
sra	SRP291010	Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damage	PRJNA674364	3-Nov-2020	P01CA210944	33452106
sra	SRP291010	Inhibitory signaling sustains a distinct early memory CD8+ T cell precursor that is resistant to DNA damage	PRJNA674364	3-Nov-2020	P01CA210944
sra	SRP285126	Cell-type, single-cell, and spatial signatures of brain-region specific splicing in postnatal development	PRJNA665252	23-Sep-2020	U24CA180996	33469025
sra	SRP285126	Cell-type, single-cell, and spatial signatures of brain-region specific splicing in postnatal development	PRJNA665252	23-Sep-2020	U24CA180996
sra	SRP239279	Global gene expression analysis of breast cancer cell line responses to Topsentinol L Trisulfate or DMSO as the vehicle control	PRJNA598573	2-Jan-2020	U54CA209978	33477536
sra	SRP239279	Global gene expression analysis of breast cancer cell line responses to Topsentinol L Trisulfate or DMSO as the vehicle control	PRJNA598573	2-Jan-2020	U54CA209978
sra	SRP292363	Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts	PRJNA677962	12-Nov-2020	U54CA224081	33479121
sra	SRP292363	Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts	PRJNA677962	12-Nov-2020	U54CA224081
sra	SRP252552	RNA editing enzyme APOBEC3A promotes pro-inflammatory (M1) macrophage polarization	PRJNA612213	12-Mar-2020	R01CA188900	33483601
sra	SRP252552	RNA editing enzyme APOBEC3A promotes pro-inflammatory (M1) macrophage polarization	PRJNA612213	12-Mar-2020	U24CA232979	33483601
sra	SRP252552	RNA editing enzyme APOBEC3A promotes pro-inflammatory (M1) macrophage polarization	PRJNA612213	12-Mar-2020	R01CA188900
sra	SRP252552	RNA editing enzyme APOBEC3A promotes pro-inflammatory (M1) macrophage polarization	PRJNA612213	12-Mar-2020	U24CA232979
sra	SRP300048	MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer	PRJNA689212	2-Jan-2021	U01CA233084	33495298
sra	SRP300048	MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer	PRJNA689212	2-Jan-2021	U24CA232979	33495298
sra	SRP300048	MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer	PRJNA689212	2-Jan-2021	U01CA233084
sra	SRP300048	MUC1-C integrates activation of the IFN-? pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer	PRJNA689212	2-Jan-2021	U24CA232979
sra	SRP306841	Convergent organization of aberrant MYB complexes controls oncogenic gene expression in acute myeloid leukemia [ChIPseq]	PRJNA702445	17-Feb-2021	R01CA204396	33527899
sra	SRP306841	Convergent organization of aberrant MYB complexes controls oncogenic gene expression in acute myeloid leukemia [ChIPseq]	PRJNA702445	17-Feb-2021	R01CA204396
sra	SRP279983	Single-cell B receptor VDJ sequencing from HGSOC isolated B cells	PRJNA661287	3-Sep-2020	R01CA211913	33536615
sra	SRP279983	Single-cell B receptor VDJ sequencing from HGSOC isolated B cells	PRJNA661287	3-Sep-2020	U01CA232758	33536615
sra	SRP279983	Single-cell B receptor VDJ sequencing from HGSOC isolated B cells	PRJNA661287	3-Sep-2020	R01CA211913
sra	SRP279983	Single-cell B receptor VDJ sequencing from HGSOC isolated B cells	PRJNA661287	3-Sep-2020	U01CA232758
sra	SRP252361	Transcriptional changes in in vitro treated OVCAR3 cells with non-specific IgG and IgA and Specific IgA antibodies	PRJNA611945	11-Mar-2020	R01CA211913	33536615
sra	SRP252361	Transcriptional changes in in vitro treated OVCAR3 cells with non-specific IgG and IgA and Specific IgA antibodies	PRJNA611945	11-Mar-2020	U01CA232758	33536615
sra	SRP252361	Transcriptional changes in in vitro treated OVCAR3 cells with non-specific IgG and IgA and Specific IgA antibodies	PRJNA611945	11-Mar-2020	R01CA211913
sra	SRP252361	Transcriptional changes in in vitro treated OVCAR3 cells with non-specific IgG and IgA and Specific IgA antibodies	PRJNA611945	11-Mar-2020	U01CA232758
sra	SRP258859	Genome-wide maps of histone modifications in mouse tumor-derived cell lines	PRJNA628863	28-Apr-2020	U54CA224065	33536620
sra	SRP258859	Genome-wide maps of histone modifications in mouse tumor-derived cell lines	PRJNA628863	28-Apr-2020	U54CA224065
sra	SRP258284	Elevated NSD3 Histone Methylation Activity Drives Squamous Cell Lung Cancer	PRJNA627861	24-Apr-2020	U54CA224065	33536620
sra	SRP258284	Elevated NSD3 Histone Methylation Activity Drives Squamous Cell Lung Cancer	PRJNA627861	24-Apr-2020	U54CA224065
sra	SRP268591	SPT6 Promotes Epidermal Differentiation and Blockade of an Intestinal Phenotype through Control of Transcriptional Elongation	PRJNA641564	24-Jun-2020	U01CA217885	33542242
sra	SRP268591	SPT6 Promotes Epidermal Differentiation and Blockade of an Intestinal Phenotype through Control of Transcriptional Elongation	PRJNA641564	24-Jun-2020	U01CA217885
sra	SRP256444	Gain-of-Function p53 Protein Transferred via Small Extracellular Vesicles Promotes Conversion of Fibroblasts to a Cancer-Associated Phenotype	PRJNA625457	15-Apr-2020	P50CA098258	33567287
sra	SRP256444	Gain-of-Function p53 Protein Transferred via Small Extracellular Vesicles Promotes Conversion of Fibroblasts to a Cancer-Associated Phenotype	PRJNA625457	15-Apr-2020	P50CA098258
sra	SRP292585	Differential expression genes analysis of knocking down Prmt1 and Ripk1 in MC38/gp100 cell line	PRJNA678452	14-Nov-2020	R01CA187076	33589527
sra	SRP292585	Differential expression genes analysis of knocking down Prmt1 and Ripk1 in MC38/gp100 cell line	PRJNA678452	14-Nov-2020	R01CA187076
sra	SRP265561	p300/CBP mediated activation of MHCI machinery and IFNg receptor loci controls chemoimmunotherapy	PRJNA636609	2-Jun-2020	U01AA027681	33602823
sra	SRP265561	p300/CBP mediated activation of MHCI machinery and IFNg receptor loci controls chemoimmunotherapy	PRJNA636609	2-Jun-2020	U24CA232979	33602823
sra	SRP265561	p300/CBP mediated activation of MHCI machinery and IFNg receptor loci controls chemoimmunotherapy	PRJNA636609	2-Jun-2020	U01AA027681
sra	SRP265561	p300/CBP mediated activation of MHCI machinery and IFNg receptor loci controls chemoimmunotherapy	PRJNA636609	2-Jun-2020	U24CA232979
sra	SRP184667	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [AT_MC]	PRJNA521486	8-Feb-2019	U01AA027681	33602823
sra	SRP184667	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [AT_MC]	PRJNA521486	8-Feb-2019	U24CA232979	33602823
sra	SRP184667	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [AT_MC]	PRJNA521486	8-Feb-2019	U01AA027681
sra	SRP184667	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [AT_MC]	PRJNA521486	8-Feb-2019	U24CA232979
sra	SRP184656	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [TRAMP]	PRJNA521468	8-Feb-2019	U01AA027681	33602823
sra	SRP184656	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [TRAMP]	PRJNA521468	8-Feb-2019	U24CA232979	33602823
sra	SRP184656	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [TRAMP]	PRJNA521468	8-Feb-2019	U01AA027681
sra	SRP184656	Platinoid drugs augment immunotherapy via histone acetylation of MHCI machinery genes [TRAMP]	PRJNA521468	8-Feb-2019	U24CA232979
sra	SRP253514	Transcriptional profiling of control versus PAF depleted human lung cancer cell line (H1792)	PRJNA613709	20-Mar-2020	U54CA224065	33626321
sra	SRP253514	Transcriptional profiling of control versus PAF depleted human lung cancer cell line (H1792)	PRJNA613709	20-Mar-2020	U54CA224065
sra	SRP219792	Transcriptional profiling of control versus PAF depleted mouse lung cancer cell lines	PRJNA562707	28-Aug-2019	U54CA224065	33626321
sra	SRP219792	Transcriptional profiling of control versus PAF depleted mouse lung cancer cell lines	PRJNA562707	28-Aug-2019	U54CA224065
sra	SRP304721	Lipid signalling enforces functional specialization of Treg cells in tumours [scRNA-seq EAE]	PRJNA699485	4-Feb-2021	R01CA221290	33627871
sra	SRP304721	Lipid signalling enforces functional specialization of Treg cells in tumours [scRNA-seq EAE]	PRJNA699485	4-Feb-2021	R01CA221290
sra	SRP302716	Lipid signalling enforces functional specialization of Treg cells in tumours [scRNA-seq]	PRJNA693833	21-Jan-2021	R01CA221290	33627871
sra	SRP302716	Lipid signalling enforces functional specialization of Treg cells in tumours [scRNA-seq]	PRJNA693833	21-Jan-2021	R01CA221290
sra	SRP273301	A bladder cancer patient-derived xenograft reflects aggressive growth dynamics in vivo and in organoids	PRJNA648129	23-Jul-2020	R37CA230617	33633154
sra	SRP273301	A bladder cancer patient-derived xenograft reflects aggressive growth dynamics in vivo and in organoids	PRJNA648129	23-Jul-2020	R37CA230617
sra	SRP295963	ArchR: An integrative and scalable software package for single-cell chromatin accessibility analysis	PRJNA682619	4-Dec-2020	U2CCA233311	33633365
sra	SRP295963	ArchR: An integrative and scalable software package for single-cell chromatin accessibility analysis	PRJNA682619	4-Dec-2020	U2CCA233311
sra	SRP289484	In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions [Pofut1 ATAC-seq]	PRJNA672934	28-Oct-2020	R01CA221290	33636132
sra	SRP289484	In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions [Pofut1 ATAC-seq]	PRJNA672934	28-Oct-2020	R01CA221290
sra	SRP289470	In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions [scRNA-seq]	PRJNA672923	28-Oct-2020	R01CA221290	33636132
sra	SRP289470	In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions [scRNA-seq]	PRJNA672923	28-Oct-2020	R01CA221290
sra	SRP253428	Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Broad Spectrum of Cancer Therapeutics and Confers Vulnerability to Replication Stress	PRJNA613594	20-Mar-2020	U54CA224079	33658518
sra	SRP253428	Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Broad Spectrum of Cancer Therapeutics and Confers Vulnerability to Replication Stress	PRJNA613594	20-Mar-2020	R37CA230617	34244513
sra	SRP253428	Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Broad Spectrum of Cancer Therapeutics and Confers Vulnerability to Replication Stress	PRJNA613594	20-Mar-2020	U54CA224079	34244513
sra	SRP253428	Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Broad Spectrum of Cancer Therapeutics and Confers Vulnerability to Replication Stress	PRJNA613594	20-Mar-2020	U54CA224079
sra	SRP253428	Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Broad Spectrum of Cancer Therapeutics and Confers Vulnerability to Replication Stress	PRJNA613594	20-Mar-2020	R37CA230617
sra	SRP313387	Regnase-1 suppresses TCF-1+ precursor exhausted T cell formation to limit CAR T cell responses against ALL [WGBS]	PRJNA719647	4-Apr-2021	R01CA221290	33690816
sra	SRP313387	Regnase-1 suppresses TCF-1+ precursor exhausted T cell formation to limit CAR T cell responses against ALL [WGBS]	PRJNA719647	4-Apr-2021	R01CA221290
sra	SRP265464	T cell receptor repertoire analysis of tumor-infiltrating T cells in non-small cell lung cancer [tumor_T_cells]	PRJNA636300	1-Jun-2020	U54CA232568	33691136
sra	SRP265464	T cell receptor repertoire analysis of tumor-infiltrating T cells in non-small cell lung cancer [tumor_T_cells]	PRJNA636300	1-Jun-2020	U54CA232568
sra	SRP292937	PolyA-sequencing in Jurkat cells upon CDK12 depletion.	PRJNA679028	17-Nov-2020	P01CA154303	33753926
sra	SRP292937	PolyA-sequencing in Jurkat cells upon CDK12 depletion.	PRJNA679028	17-Nov-2020	P01CA154303
sra	SRP309720	Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19	PRJNA707445	8-Mar-2021	P01AI118688	33758859
sra	SRP309720	Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19	PRJNA707445	8-Mar-2021	P01AI118688
sra	SRP284880	Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages	PRJNA664962	22-Sep-2020	U01CA224145	33782087
sra	SRP284880	Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages	PRJNA664962	22-Sep-2020	U01CA224145
sra	SRP301988	Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells Mediate Enhanced Antitumor Activity [ATAC-seq]	PRJNA692498	15-Jan-2021	U54CA232568	33795428
sra	SRP301988	Transient “rest” induces functional reinvigoration and epigenetic remodeling in exhausted CAR-T cells Mediate Enhanced Antitumor Activity [ATAC-seq]	PRJNA692498	15-Jan-2021	U54CA232568
sra	SRP285593	Human MSI colon cancer	PRJNA666078	28-Sep-2020	U2CCA233291	33837131
sra	SRP285593	Human MSI colon cancer	PRJNA666078	28-Sep-2020	U2CCA233291
sra	SRP238563	Splicing Variation Contributes to Functional Dysregulation of Genes in Acute Myeloid Leukemia	PRJNA597243	22-Dec-2019	U01CA232563	33876749
sra	SRP238563	Splicing Variation Contributes to Functional Dysregulation of Genes in Acute Myeloid Leukemia	PRJNA597243	22-Dec-2019	U01CA232563
sra	SRP292529	CRISPR genome editing of human dendritic cells (treatments of knockout dendritic cells)	PRJNA678348	13-Nov-2020	U54CA224081	33904395
sra	SRP292529	CRISPR genome editing of human dendritic cells (treatments of knockout dendritic cells)	PRJNA678348	13-Nov-2020	U54CA224081
sra	SRP310875	Human stem cell-derived pancreatic acini-like and duct-like organoids demonstrate lineage-specific differences to oncogene activation	PRJNA714896	16-Mar-2021	U01CA224193	33915081
sra	SRP310875	Human stem cell-derived pancreatic acini-like and duct-like organoids demonstrate lineage-specific differences to oncogene activation	PRJNA714896	16-Mar-2021	U01CA224193
sra	SRP308387	Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas	PRJNA705184	26-Feb-2021	R01CA208205	33976133
sra	SRP308387	Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas	PRJNA705184	26-Feb-2021	U01CA224348	33976133
sra	SRP308387	Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas	PRJNA705184	26-Feb-2021	U2CCA233262	33976133
sra	SRP308387	Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas	PRJNA705184	26-Feb-2021	R01CA208205
sra	SRP308387	Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas	PRJNA705184	26-Feb-2021	U01CA224348
sra	SRP308387	Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas	PRJNA705184	26-Feb-2021	U2CCA233262
sra	SRP261101	cIAP1/2 antagonism eliminates MHC class I negative tumors through T cell-dependent reprogramming of mononuclear phagocytes	PRJNA631697	11-May-2020	U01CA224146	34011631
sra	SRP261101	cIAP1/2 antagonism eliminates MHC class I negative tumors through T cell-dependent reprogramming of mononuclear phagocytes	PRJNA631697	11-May-2020	U01CA224146
sra	SRP261100	cIAP1/2 antagonism eliminates MHC class I negative tumors through T cell-dependent reprogramming of mononuclear phagocytes	PRJNA631699	11-May-2020	U01CA224146	34011631
sra	SRP261100	cIAP1/2 antagonism eliminates MHC class I negative tumors through T cell-dependent reprogramming of mononuclear phagocytes	PRJNA631699	11-May-2020	U01CA224146
sra	SRP261099	cIAP1/2 antagonism eliminates MHC class I negative tumors through T cell-dependent reprogramming of mononuclear phagocytes	PRJNA631698	11-May-2020	U01CA224146	34011631
sra	SRP261099	cIAP1/2 antagonism eliminates MHC class I negative tumors through T cell-dependent reprogramming of mononuclear phagocytes	PRJNA631698	11-May-2020	U01CA224146
sra	SRP290695	Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-kB-mediated production of CXCL1	PRJNA673706	1-Nov-2020	U01CA224145	34049975
sra	SRP290695	Apolipoprotein E promotes immune suppression in pancreatic cancer through NF-kB-mediated production of CXCL1	PRJNA673706	1-Nov-2020	U01CA224145
sra	SRP320538	Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer [BiSulfite-seq]	PRJNA731168	19-May-2021	U24CA232979	34075163
sra	SRP320538	Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer [BiSulfite-seq]	PRJNA731168	19-May-2021	U24CA232979
sra	SRP320389	Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer [Methyl Capture]	PRJNA730913	18-May-2021	U24CA232979	34075163
sra	SRP320389	Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer [Methyl Capture]	PRJNA730913	18-May-2021	U24CA232979
sra	SRP320306	Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer	PRJNA730799	18-May-2021	U24CA232979	34075163
sra	SRP320306	Dynamic patterns of DNA methylation in the normal prostate epithelial differentiation program are targets of aberrant methylation in prostate cancer	PRJNA730799	18-May-2021	U24CA232979
sra	SRP270319	Tumor transcriptomes profiling of SS18-SSX, Smarcb1-/- and combination of SS18-SSX and Smarcb1-/- driven tumor	PRJNA644360	6-Jul-2020	U54CA231652	34078620
sra	SRP270319	Tumor transcriptomes profiling of SS18-SSX, Smarcb1-/- and combination of SS18-SSX and Smarcb1-/- driven tumor	PRJNA644360	6-Jul-2020	U54CA231652
sra	SRP277341	TNF blockade uncouples toxicity and anti-tumor efficacy induced with an agonist CD40 antibody	PRJNA656939	13-Aug-2020	U01CA224193	34101617
sra	SRP277341	TNF blockade uncouples toxicity and anti-tumor efficacy induced with an agonist CD40 antibody	PRJNA656939	13-Aug-2020	U01CA224193
sra	SRP286808	PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer [3D]	PRJNA668175	8-Oct-2020	U54CA224076	34103681
sra	SRP286808	PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer [3D]	PRJNA668175	8-Oct-2020	U54CA224076
sra	SRP186309	MCF-7 cell RNA-seq analysis of PELP1-induced gene expression	PRJNA523244	19-Feb-2019	U54CA224076	34103681
sra	SRP186309	MCF-7 cell RNA-seq analysis of PELP1-induced gene expression	PRJNA523244	19-Feb-2019	U54CA224076
sra	SRP301757	High-fat diet activated fatty acid oxidation mediates intestinal stemness and tumorigenicity	PRJNA692179	14-Jan-2021	U01CA250554	34107251
sra	SRP301757	High-fat diet activated fatty acid oxidation mediates intestinal stemness and tumorigenicity	PRJNA692179	14-Jan-2021	U54CA224068	34107251
sra	SRP301757	High-fat diet activated fatty acid oxidation mediates intestinal stemness and tumorigenicity	PRJNA692179	14-Jan-2021	U01CA250554
sra	SRP301757	High-fat diet activated fatty acid oxidation mediates intestinal stemness and tumorigenicity	PRJNA692179	14-Jan-2021	U54CA224068
sra	SRP302344	Longitudinal single-cell dynamics in chronic lymphocytic leukemia mirror disease history	PRJNA693244	19-Jan-2021	U24CA224331	34112698
sra	SRP302344	Longitudinal single-cell dynamics in chronic lymphocytic leukemia mirror disease history	PRJNA693244	19-Jan-2021	U24CA224331
sra	SRP318107	mSWI/SNF promotes polycomb repression both directly and through genome-wide redistribution [ChIP-seq]	PRJNA726623	29-Apr-2021	R01CA163915	34117481
sra	SRP318107	mSWI/SNF promotes polycomb repression both directly and through genome-wide redistribution [ChIP-seq]	PRJNA726623	29-Apr-2021	R01CA163915
sra	SRP303823	The effect of STAG2 loss in Ewing sarcoma [ChIP-seq]	PRJNA697910	29-Jan-2021	R01CA204915	34129824
sra	SRP303823	The effect of STAG2 loss in Ewing sarcoma [ChIP-seq]	PRJNA697910	29-Jan-2021	R01CA204915
sra	SRP304269	The effect of STAG2 loss in Ewing sarcoma [HiChIP]	PRJNA698886	2-Feb-2021	R01CA204915	34129824
sra	SRP304269	The effect of STAG2 loss in Ewing sarcoma [HiChIP]	PRJNA698886	2-Feb-2021	R01CA204915
sra	SRP267182	Visualizing programmed lineage trajectories at cancer initiation	PRJNA639282	13-Jun-2020	U24CA209923	34131071
sra	SRP267182	Visualizing programmed lineage trajectories at cancer initiation	PRJNA639282	13-Jun-2020	U24CA209923
sra	SRP221563	Characterization of transcriptional analysis of LKB1 mutant lung nodules	PRJNA565371	13-Sep-2019	U01CA233084	34142094
sra	SRP221563	Characterization of transcriptional analysis of LKB1 mutant lung nodules	PRJNA565371	13-Sep-2019	U01CA233084
sra	SRP221293	Characterization of tumor mutational burden in LKB1 mutant lung tumors	PRJNA564852	10-Sep-2019	U01CA233084	34142094
sra	SRP221293	Characterization of tumor mutational burden in LKB1 mutant lung tumors	PRJNA564852	10-Sep-2019	U01CA233084
sra	SRP254894	Chromatin Occupancy of AR, BRD4, and H3K27Ac in MR42D Cells in response to Enzalutamide [RNA-seq]	PRJNA622461	1-Apr-2020	P50CA186786	34145028
sra	SRP254894	Chromatin Occupancy of AR, BRD4, and H3K27Ac in MR42D Cells in response to Enzalutamide [RNA-seq]	PRJNA622461	1-Apr-2020	U54CA224079	34145028
sra	SRP254894	Chromatin Occupancy of AR, BRD4, and H3K27Ac in MR42D Cells in response to Enzalutamide [RNA-seq]	PRJNA622461	1-Apr-2020	P50CA186786
sra	SRP254894	Chromatin Occupancy of AR, BRD4, and H3K27Ac in MR42D Cells in response to Enzalutamide [RNA-seq]	PRJNA622461	1-Apr-2020	U54CA224079
sra	SRP318897	Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer [tumor]	PRJNA728069	7-May-2021	R01CA229164	34161764
sra	SRP318897	Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer [tumor]	PRJNA728069	7-May-2021	R01CA229164
sra	SRP318892	Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer [Mammary fat pad, MFP]	PRJNA728059	7-May-2021	R01CA229164	34161764
sra	SRP318892	Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer [Mammary fat pad, MFP]	PRJNA728059	7-May-2021	R01CA229164
sra	SRP285763	Genome-wide CRISPR rensensitization screens in FGF2 and FL-derived Early and Late Gilteritinib Resistant MOLM14 cultures using  Y. Kosuke library	PRJNA666344	29-Sep-2020	U54CA224019	34171263
sra	SRP285763	Genome-wide CRISPR rensensitization screens in FGF2 and FL-derived Early and Late Gilteritinib Resistant MOLM14 cultures using  Y. Kosuke library	PRJNA666344	29-Sep-2020	U54CA224019
sra	SRP293634	Transcriptome Analysis of treated cells in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia	PRJNA679952	21-Nov-2020	U01CA232486	34210682
sra	SRP293634	Transcriptome Analysis of treated cells in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia	PRJNA679952	21-Nov-2020	U01CA232486
sra	SRP319403	10X Genomics single-cell RNAseq combined with CRISPR tiling of Dot1l in mouse MLL-AF9 leukemia	PRJNA729273	12-May-2021	R01CA176745	34210975
sra	SRP319403	10X Genomics single-cell RNAseq combined with CRISPR tiling of Dot1l in mouse MLL-AF9 leukemia	PRJNA729273	12-May-2021	R01CA176745
sra	SRP322468	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA734933	3-Jun-2021	R01AI084880	34215680
sra	SRP322468	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA734933	3-Jun-2021	R01CA208205	34215680
sra	SRP322468	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA734933	3-Jun-2021	U01CA224348	34215680
sra	SRP322468	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA734933	3-Jun-2021	R01AI084880
sra	SRP322468	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA734933	3-Jun-2021	R01CA208205
sra	SRP322468	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA734933	3-Jun-2021	U01CA224348
sra	SRP321779	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA733462	28-May-2021	R01AI084880	34215680
sra	SRP321779	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA733462	28-May-2021	R01CA208205	34215680
sra	SRP321779	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA733462	28-May-2021	U01CA224348	34215680
sra	SRP321779	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA733462	28-May-2021	R01AI084880
sra	SRP321779	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA733462	28-May-2021	R01CA208205
sra	SRP321779	Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy	PRJNA733462	28-May-2021	U01CA224348
sra	SRP320718	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (Exome-Seq)	PRJNA731519	20-May-2021	R37CA230617	34244513
sra	SRP320718	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (Exome-Seq)	PRJNA731519	20-May-2021	U54CA224079	34244513
sra	SRP320718	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (Exome-Seq)	PRJNA731519	20-May-2021	R37CA230617
sra	SRP320718	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (Exome-Seq)	PRJNA731519	20-May-2021	U54CA224079
sra	SRP314066	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (RNASeq)	PRJNA720674	8-Apr-2021	R37CA230617	34244513
sra	SRP314066	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (RNASeq)	PRJNA720674	8-Apr-2021	U54CA224079	34244513
sra	SRP314066	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (RNASeq)	PRJNA720674	8-Apr-2021	R37CA230617
sra	SRP314066	Multiplexed functional genomic analysis of somatic 5' untranslated region mutations across the spectrum of human prostate cancer (RNASeq)	PRJNA720674	8-Apr-2021	U54CA224079
sra	SRP272605	BATF and IRF4 cooperate to counter exhaustion in tumour-infiltrating CAR T cells (ChIP-seq)	PRJNA647369	20-Jul-2020	U01DE028227	34282330
sra	SRP272605	BATF and IRF4 cooperate to counter exhaustion in tumour-infiltrating CAR T cells (ChIP-seq)	PRJNA647369	20-Jul-2020	U01DE028227
sra	SRP272607	BATF and IRF4 cooperate to counter exhaustion in tumour-infiltrating CAR T cells (RNA-seq)	PRJNA647370	20-Jul-2020	U01DE028227	34282330
sra	SRP272607	BATF and IRF4 cooperate to counter exhaustion in tumour-infiltrating CAR T cells (RNA-seq)	PRJNA647370	20-Jul-2020	U01DE028227
sra	SRP327407	RNA-seq on NUT Carcinoma (NC) cell lines treated with DMSO, Panobinostat or IRBM6	PRJNA744556	7-Jul-2021	R01CA124633	34285087
sra	SRP327407	RNA-seq on NUT Carcinoma (NC) cell lines treated with DMSO, Panobinostat or IRBM6	PRJNA744556	7-Jul-2021	R01CA124633
sra	SRP327405	ChIP-seq analysis of BRD4-NUT and H3K27ac distribution in NUT Carcinoma cell line TC-797 treated with DMSO or Panobinostat	PRJNA744553	7-Jul-2021	R01CA124633	34285087
sra	SRP327405	ChIP-seq analysis of BRD4-NUT and H3K27ac distribution in NUT Carcinoma cell line TC-797 treated with DMSO or Panobinostat	PRJNA744553	7-Jul-2021	R01CA124633
sra	SRP285426	RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroendocrine prostate cancer [RNA-seq]	PRJNA665740	25-Sep-2020	P50CA186786	34312180
sra	SRP285426	RNA splicing factors SRRM3 and SRRM4 distinguish molecular phenotypes of castration-resistant neuroendocrine prostate cancer [RNA-seq]	PRJNA665740	25-Sep-2020	P50CA186786
sra	SRP255626	SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization	PRJNA623590	7-Apr-2020	U01CA224146	34320363
sra	SRP255626	SMAD4 represses FOSL1 expression and pancreatic cancer metastatic colonization	PRJNA623590	7-Apr-2020	U01CA224146
sra	SRP261076	RNA-seq profiling of Ewing sarcoma cells after TRIM8 knockout and EWS/FLI over-expression	PRJNA631627	11-May-2020	R01CA204915	34329586
sra	SRP261076	RNA-seq profiling of Ewing sarcoma cells after TRIM8 knockout and EWS/FLI over-expression	PRJNA631627	11-May-2020	U54CA231637	34329586
sra	SRP261076	RNA-seq profiling of Ewing sarcoma cells after TRIM8 knockout and EWS/FLI over-expression	PRJNA631627	11-May-2020	U54CA231641	34329586
sra	SRP261076	RNA-seq profiling of Ewing sarcoma cells after TRIM8 knockout and EWS/FLI over-expression	PRJNA631627	11-May-2020	R01CA204915
sra	SRP261076	RNA-seq profiling of Ewing sarcoma cells after TRIM8 knockout and EWS/FLI over-expression	PRJNA631627	11-May-2020	U54CA231637
sra	SRP261076	RNA-seq profiling of Ewing sarcoma cells after TRIM8 knockout and EWS/FLI over-expression	PRJNA631627	11-May-2020	U54CA231641
sra	SRP325983	CXCR6 Positions Cytotoxic T Cells to Receive Critical Survival Signals in the Tumor Microenvironment	PRJNA742240	29-Jun-2021	R01AI084880	34343496
sra	SRP325983	CXCR6 Positions Cytotoxic T Cells to Receive Critical Survival Signals in the Tumor Microenvironment	PRJNA742240	29-Jun-2021	R01AI084880
sra	SRP282058	Labile Iron Release Primes Pancreatic Cancer for Ferroptosis	PRJNA662926	11-Sep-2020	U01CA224145	34381026
sra	SRP282058	Labile Iron Release Primes Pancreatic Cancer for Ferroptosis	PRJNA662926	11-Sep-2020	U01CA224145
sra	SRP324489	Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children	PRJNA738854	17-Jun-2021	U01DK124165	34381049
sra	SRP324489	Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children	PRJNA738854	17-Jun-2021	U24CA224319	34381049
sra	SRP324489	Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children	PRJNA738854	17-Jun-2021	U01DK124165
sra	SRP324489	Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children	PRJNA738854	17-Jun-2021	U24CA224319
sra	SRP331008	RNA-Seq of MSK-PCa series of Patient Derived Organoids and Xenografts	PRJNA751853	3-Aug-2021	R37CA230617	34417459
sra	SRP331008	RNA-Seq of MSK-PCa series of Patient Derived Organoids and Xenografts	PRJNA751853	3-Aug-2021	U54CA224079	34417459
sra	SRP331008	RNA-Seq of MSK-PCa series of Patient Derived Organoids and Xenografts	PRJNA751853	3-Aug-2021	R37CA230617
sra	SRP331008	RNA-Seq of MSK-PCa series of Patient Derived Organoids and Xenografts	PRJNA751853	3-Aug-2021	U54CA224079
sra	SRP330081	Dietary suppression of MHC-II expression in intestinal epithelial cells enhances intestinal tumorigenesis	PRJNA750096	27-Jul-2021	U01CA250554	34529935
sra	SRP330081	Dietary suppression of MHC-II expression in intestinal epithelial cells enhances intestinal tumorigenesis	PRJNA750096	27-Jul-2021	U01CA250554
sra	SRP314343	Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation	PRJNA721176	11-Apr-2021	P01CA155258	34568832
sra	SRP314343	Bortezomib induces anti-multiple myeloma immune response mediated by cGAS/STING pathway activation	PRJNA721176	11-Apr-2021	P01CA155258
sra	SRP295518	Chromatin accessibility associates with protein-RNA correlation in human cancer	PRJNA682135	2-Dec-2020	U2CCA233311	34593797
sra	SRP295518	Chromatin accessibility associates with protein-RNA correlation in human cancer	PRJNA682135	2-Dec-2020	U2CCA233311
sra	SRP309174	Pathway Signatures Derived from On-treatment Tumor Specimens Predict Response to Anti-PD1 Blockade in Metastatic Melanoma	PRJNA706446	3-Mar-2021	U54CA224070	34654806
sra	SRP309174	Pathway Signatures Derived from On-treatment Tumor Specimens Predict Response to Anti-PD1 Blockade in Metastatic Melanoma	PRJNA706446	3-Mar-2021	U54CA224070
sra	SRP256724	Potent androgen receptor inhibition unleashes oncogenic action of the KLF5 stem cell transcription factor in castration-resistant prostate cancer [ChIP-seq]	PRJNA625790	16-Apr-2020	R37CA230617	34737261
sra	SRP256724	Potent androgen receptor inhibition unleashes oncogenic action of the KLF5 stem cell transcription factor in castration-resistant prostate cancer [ChIP-seq]	PRJNA625790	16-Apr-2020	R37CA230617
sra	SRP256723	Potent androgen receptor inhibition unleashes oncogenic action of the KLF5 stem cell transcription factor in castration-resistant prostate cancer [RNA-seq]	PRJNA625789	16-Apr-2020	R37CA230617	34737261
sra	SRP256723	Potent androgen receptor inhibition unleashes oncogenic action of the KLF5 stem cell transcription factor in castration-resistant prostate cancer [RNA-seq]	PRJNA625789	16-Apr-2020	R37CA230617
sra	SRP301119	Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam (ATAC-Seq)	PRJNA691027	10-Jan-2021	U01CA232488	34788094
sra	SRP301119	Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam (ATAC-Seq)	PRJNA691027	10-Jan-2021	U01CA232488
sra	SRP301121	Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam  (RNA-Seq)	PRJNA691032	10-Jan-2021	U01CA232488	34788094
sra	SRP301121	Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam  (RNA-Seq)	PRJNA691032	10-Jan-2021	U01CA232488
sra	SRP294135	Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma	PRJNA680750	25-Nov-2020	U2CCA233195	34795254
sra	SRP294135	Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma	PRJNA680750	25-Nov-2020	U2CCA233238	34795254
sra	SRP294135	Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma	PRJNA680750	25-Nov-2020	UM1CA154967	34795254
sra	SRP294135	Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma	PRJNA680750	25-Nov-2020	U2CCA233195
sra	SRP294135	Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma	PRJNA680750	25-Nov-2020	U2CCA233238
sra	SRP294135	Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma	PRJNA680750	25-Nov-2020	UM1CA154967
sra	SRP268138	Predicting master transcription factors from pan-cancer expression data	PRJNA640799	20-Jun-2020	P01CA155258	34818047
sra	SRP268138	Predicting master transcription factors from pan-cancer expression data	PRJNA640799	20-Jun-2020	P01CA155258
sra	SRP335232	Phenotypic consequences of SLC25A40-ABCB1 fusions beyond drug resistance in High Grade Serous Ovarian Cancer	PRJNA759615	1-Sep-2021	U54CA209978	34830797
sra	SRP335232	Phenotypic consequences of SLC25A40-ABCB1 fusions beyond drug resistance in High Grade Serous Ovarian Cancer	PRJNA759615	1-Sep-2021	U54CA209978
